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Abstract 
Postoperative pain is a commonly discussed topic in patients undergoing anesthesia for 
cardiac and thoracic surgery. Uncontrolled or poorly treated postoperative pain has been 
studied to cause poor outcomes in patients. Prolonged pain experienced by the patient can 
increase the risk of infection, respiratory compromise, development of chronic pain, and 
death. Current studies look at multiple modalities of treatment of postoperative pain, 
however, a long acting drug that is often under looked and underused is methadone. 
Methadone has a prolonged effect that can provide analgesia for an extended period of 
time. ). The purpose of this paper is to conduct a systematic review to determine if 
intraoperative methadone administration will affect postoperative pain after 
cardiothoracic and thoracic surgery as evidenced by pain score levels and documented 
postoperative opioid use. This systematic review was created using guidelines put forth 
by both PRISMA and CONSORT. A literature review was performed, and data was 
gathered from each study. A cross study analysis was performed using data collection 
tables designed by the author of this systematic review. Methadone was found to have a 
prolonged effect, but evidence was inconclusive due to many limitations by each of the 
studies. It is suggested that methadone should be further evaluated in additional 
systematic reviews.  
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Background/Statement of the Problem 
Surgery is one of the most predictable and common sources of pain in 
hospitalized patients and is an expected outcome for patients undergoing some type of 
surgical intervention or procedure. Incisions through layers of tissue and muscle, along 
with the trauma of the surgical procedure itself can cause a variety in intensity of pain in 
the surgical setting. In 2010, the performance of 48.3 million surgical and nonsurgical 
procedures were recorded as visits to both ambulatory surgical centers and hospitals 
(Hall, Schwartzman, Zhang & Liu, 2017). It is estimated that in over 80% of surgical 
patients within the United States, postoperative pain is not sufficiently managed (Gan, 
2017). While this statistic widely varies with type of surgical procedure, the medications 
and anesthetics used intra-operatively and postoperatively, complications, and time 
elapsed after surgery, the results remain significant (Gan, 2017). Poorly controlled 
postoperative pain in the acute stages increase morbidity risk, impair functional and 
quality of life, delay recovery time, increase health care cost, and increase the duration of 
opioid usage (Gan, 2017).  The presence and high intensity of acute pain in the post-
surgical setting highly correlates with the development of chronic pain (Gan, 2017). 
Furthermore, the development of chronic pain contributes to disability, interferes with 
routine activities and employment, further increases healthcare spending, reduces quality 
of life and can contribute to mortality.   
 Multiple modalities of pain management can be offered by providers, but 
preference to certain drugs can impact the provider’s choice of management, rather than 
patient specific considerations. A provider’s lack of understanding regarding 
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pathophysiology of pain, or the pharmacodynamics of the large variety of drugs can limit 
options considered for pain management. This practice potentially excludes the use of 
medications that have properties that would allow for the most optimal patient outcomes. 
The standard of care for pain management in the acute postoperative phase is still opioid 
prescriptions (Gan, 2017).  
The Joint Commission is an organization involved in accreditation of healthcare 
organizations with the aim to continuously improve the quality and safety of care that is 
provided to the public (The Joint Commission, 2018). The commission evaluates aspects 
of healthcare and creates standards and goals in which healthcare providers are urged to 
follow to support performance improvements in health care organizations throughout The 
United States. In 2001, The Joint Commission noted the underassessment and 
undertreatment of pain and introduced standards for providers to appropriately monitor, 
document and treat pain (The Joint Commission, 2017). In addition to these standards, 
The American Society of Anesthesiologists (ASA) developed guidelines to assist 
providers in selecting pain management options in the perioperative phase, however, 
nationwide protocols are not in place for types of procedures, with regard to specific type 
of pain management techniques (The American Society of Anesthesiologists, 2012). 
Since surgical patients may range in age, comorbidities, pain tolerance, allergies, and 
medication side effects, and more, standards are difficult to develop in offering providers 
a protocol to follow while managing pain, especially in the postoperative period. 
Additionally, anesthetic management throughout the perioperative period is typically 
patient specific and individualized to patient needs. Furthermore, with recent issues 
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surrounding the opioid epidemic and abuse of prescription drugs in the United States, 
providers are left confused and less willing to write prescriptions that would offer 
adequate pain management, fearing abuse and addiction (The Joint Commission, 2017).  
One drug in the method of pain management that is typically overlooked is the 
use of methadone. Methadone is a synthetic opioid with similar properties to morphine. It 
has a much longer duration of action, which ranges widely among individuals, which 
could allow for improvement of pain management in the postoperative phase. It is 
commonly noted as one of the main drugs of choice for treatment of drug dependence 
and is often overlooked in pain management in the perioperative setting (Kharasch, 
2011). The purpose of this paper is to conduct a systematic review to determine if 
intraoperative methadone administration will affect postoperative pain after 
cardiothoracic and thoracic surgery as evidenced by pain score levels and documented 
postoperative opioid use. 
 Next, a review of the literature will be presented.  
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Literature Review 
 An extensive search of literature was performed using the following databases: 
CINAHL, PubMed, Ovid, Medline Plus and Cochrane Library. The search was limited to 
articles by the following factors: published in the English language from 1990 throughout 
the current year and those applicable to subject topic. Search terms included: “pain,” “pain 
management,” “cardiothoracic surgery,” “cardiac surgery,” “thoracic surgery,” 
“methadone,” “postoperative pain,” “acute pain,” and “chronic pain.” 
Pain Definition and Etiology 
 Defined by The International Association for the Study of Pain (IASP), pain is 
defined as “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms of such damage” (IASP, 2017). While pain 
is typically evaluated as a negative experience, it has had a positive impact on the human 
species. Often, pain can indicate certain health issues, such as disruption in normal organ 
function, injury, infection or cancerous lesion.  
One of the most commonly known causes of pain is related to surgical procedures 
or medical interventions. The perioperative phase involves all phases of surgery, 
including preoperative and postoperative. Pain can occur in all of these phases. Patients 
may experience pain in the preoperative period, otherwise known as the period prior to 
surgery, which can be related or unrelated to their planned procedure. During the 
intraoperative phase, or the time the patient is being treated within the operating room, 
patients are exposed to many types of painful stimuli, such as initial incision or 
uncomfortable positioning required to complete the planned procedure. Lastly, the most 
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common occurrence of pain in the perioperative setting is postoperatively, or the period 
of time after the surgery and during the patient’s period of recovery. In addition to an 
unpleasant sensation, pain throughout the entire perioperative phase can contribute to 
negative effects on patient’s health and recovery, including prolonged hospital stays, 
which can further lead to increased co-morbidities and complications (Hutchinson, 2007). 
 The etiology of pain is rather complex but can be simplified into an overall 
neurological-sensing pathway. Disruptions in normal tissue integrity caused by 
mechanical, thermal or chemical means cause nociceptive neurons to increase the rate of 
discharge and send signals to the brain for the body to recognize the sensation of pain 
(Carr & Goudas, 1999).  Depending on the type and degree of pain, nociceptors can have 
different responses and the rate of discharge based on the stimulus intensity (Carr & 
Goudas, 1999). In a state of tissue destruction and the activation of nociceptors, the body 
emits a local inflammatory, immune and mediated cell responses (Car & Goudas, 1999). 
Nociceptive information is then conveyed from the site of pain to the dorsal horn of the 
spinal cord and through the thalamic, limbic, and cortical structures that are accountable 
for the perception of the affective and discriminative responses to the body (Carr & 
Goudas, 1999).  
 Acute pain is a type of pain that is often experienced in the perioperative phases. 
It is defined as pain that is short in duration and serves the purpose of warning of illness 
or injury, hence stimulating the sympathetic nervous system to elicit the “fight or flight” 
response (Helms & Barone, 2008). This response includes increased heart rate and 
respiratory rate, apprehension, restlessness, sweating and dilated pupils; symptoms that 
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can be recognized and objectively measured by providers in operative patients (Helms & 
Barone, 2008). Different subsets of acute pain include somatic, visceral and referred. 
Somatic pain is related to pain elicited at, or near skin or subcutaneous tissues, visceral 
pertains to the internal organs, and referred pain is pain that is felt in an area distant from 
the stimulus site (Helms & Barone, 2008). Diseases, injury, trauma and surgical incisions 
can elicit all three of these types of acute pain. 
Postoperative Pain   
Postoperative pain is pain that is felt after a surgical procedure or intervention and 
varies greatly among patients. Acute pain in the immediate post-surgical setting is 
typically due to the activation of nociceptors, inflammatory mechanisms, and possible 
nerve injury (Kehlet, Jensen & Woolf, 2006). For this reason, in the initial phases, pain is 
often described by patients as a spontaneous throbbing or discomfort while resting, in 
addition to breakthrough pain at the surgical site and surrounding tissues after pain 
medication has been administered (Kehlet et al., 2006). Movement to the affected 
surgical location, touching, breathing, coughing, and poor gastrointestinal mobility after 
surgery, are further factors that can evoke or increase the pain experience (Kehlet, et al., 
2006).  
Despite the increasing awareness of pain and the many guidelines set forth to 
manage postoperative pain, it still remains a major challenge in patients who undergo 
surgical procedures. According to The Institute of Medicine (2011), approximately 60% 
of surgical procedures within the United States are performed within outpatient settings 
and patients are discharged to home the same day. In this population, adequate pain 
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assessments may not be accurately assessed. Patients are likely to be discharged to home 
with lingering anesthetics, opioids or regional nerve blocks, and may not experience a 
high level of postoperative pain upon discharge, in comparison to the amount of pain they 
may feel once they are at home, hours later. Inadequate pain management, or poor choice 
in pain management strategy, can have a large impact on reported pain after surgery. In 
addition, patients may not comply with pain regimen, may not understand the education 
they received regarding treatment of pain, or be fearful to take opioids causing inadequate 
pain relief, or on the contrary, inappropriately self-manage prescription drug dosages or 
scheduling (Jafra & Mitra, 2018).  
Postoperative Pain Evaluation. Apfelbaum, Chen, Mehta and Gan (2003) 
hypothesized that although pain is a common experience following surgery, it is 
inadequately managed in most surgical populations. They further emphasized that 
postoperative pain has profound consequences on patient’s health and recovery. In a 
survey of 250 post-surgical patients, Apfelbaum, et al., (2003) found that 80% of 
respondents that had any type of surgery in the past five years reported acute pain after a 
variety of surgical procedures, ranging from those performed within hospital inpatient, 
outpatient, physician office or outpatient surgical centers. Of this 80% reporting acute 
pain, 75% further reported pain after they had been discharged, in comparison to 58% of 
patients who reported pain prior to discharge (Apfelbaum et al., 2003).  The study also 
reported that 59% of patients expressed their primary concern for surgery was the 
experience of postoperative pain, and 8% postponed their procedures due to fear of 
postoperative pain (Apfelbaum et al., 2003). 
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In a study conducted by Zheng et al. (2017), 890 patients were evaluated after 
orthopedic surgery with regard to the impact on postoperative pain and compared 
variables such as age, sex, preoperative chronic pain and anesthetic technique. The 
authors found the most significant differences in postoperative pain reporting were in 
patients who were older than 50 years, female, or those with preoperative chronic pain. 
The researchers used questionnaires to inquire about postoperative pain intensity, 
interference of pain with activities and feelings, side effects of medications administered, 
and the satisfaction of the care received (Zheng et al., 2017).  Zheng at al. (2017) found 
that the mean amount of time spent in severe pain was 30%, and women reported a 
longer period of time in severe pain than men (p < 0.001). All patients reported that their 
postoperative pain interfered with physical activities, and on the numerical rating scale 
(NRS) evaluating anxiety and helplessness, all patients reported an increased anxiety 
level of 2.40 ± 2.46, related to their pain (Zheng et al., 2017). In addition, all patients 
reported the feeling of helplessness due to pain at 2.68 ± 2.87 on the NRS (Zheng et al., 
2017).  
Zheng et al. (2017), found that the mean postoperative opioid consumption in all 
patients was 0.346 mg/kg (± 0.456) morphine equivalents (ME), with women using more 
opioids than men. Female consumption was measured at 0.39 mg/kg ± 0.50 (ME) and 
male was 0.31 mg/kg ± 0.41(ME) (Zheng et al., 2017). Despite the increased 
consumption of opioids in women, both gender groups reported the mean amount of pain 
relief was 62% (± 27%), and Zheng et al. (2017) inferred that sex differences did not 
show significance in pain intensity ratings. Age was also evaluated in two groups and 
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compared by participants under the age of 50 to those over the age of 50. Analysis of 
these groups showed that the older age group of women received a significantly reduced 
amount of pain relief compared to men (p = 0.040). In contrast, the younger age group of 
women experienced a higher amount of pain relief than compared to the men (p = 0.025). 
Zheng et al. (2017) reported 17.7% of all patients included in the study stated they would 
have preferred to receive better pain management. The mean satisfaction among all the 
patients in the study was 7.57 (± 2.77) on a numerical rating scale 0-10 (Zheng et al., 
2017).  
Although pain is an anticipated experience after surgery, it is also a highly feared 
sensation and can impede patients from seeking surgical treatments. In the two studies by 
Zheng et al., (2017) and Apfelbaum et al. (2003), pain is highlighted as a serious 
condition that can greatly interfere with patient’s well-being, satisfaction and even 
contribute to chronic pain syndromes. It is important to trend factors, such as age, gender, 
preoperative pain, amount of opioid administered, and postoperative pain scores, in order 
to understand and formulate effective treatment strategies.  
 Measurement of Postoperative Pain. Pain is considered a subjective sensation 
and patients self-reporting of pain is one of the primary considerations in the plan of care. 
Pain intensity measurements are a prerequisite in the decision of treatment modalities for 
proper pain management (Nagelhout & Plaus, 2014). Reporting scales, such as the visual 
analog scale (VAS) and the numerical rating scale (NRS) assess level of pain and are 
clinically relevant in measuring pain intensity (Nagelhout & Plaus, 2014). Each scale 
uses the goal to allow the patient to assign a value to level of pain they are experiencing. 
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This information can be used to direct the provider in formulating the most effective type 
of treatment and dose.    
 Visual Analog Scale. The VAS is a continuous scale consisting of 100mm 
vertical or horizontal lines with extremes labeled as worst imaginable pain and zero pain 
(Kliger et al., 2014). Patients are instructed to mark the intensity of the pain being felt on 
a line between the two extremes. This option allows providers to monitor the amount of 
pain the patient is experiencing, and plan strategies based on that exam. The VAS does 
not require the patient to have verbal or reading skills and is versatile and can be used in a 
wide variety of settings (Kliger et al., 2014). Disadvantages of this scale include the 
requirement of visual acuity and the patient’s ability to convert pain experience to an 
abstract scale (Kliger et al., 2014). For these reasons, it has been reported the VAS has a 
failure rate of 7-16%, especially in elderly, young children, handicapped and mentally 
challenged populations of patients (Kliger et al., 2014). 
Numeric Rating Scale. Similar to the VAS, the NRS is an 11-point scale that 
patients use to provide a value from 0-10 regarding the intensity of their pain. A score of 
0 indicates no pain and a score of 10 indicated the worst imaginable pain (van Dijk, 
Kappen, Schuurmans, & van Wijck, 2014). The VAS and NRS are very similar in 
approach to acquiring pain score from an individual, although the VAS has a visual key 
that can be utilized by the patient to point to, rather than the NRS in which patients 
typically assign a number to their pain without the use of visual aids. Therefore, these 
two scales have similar advantages and disadvantages. The ease of the NRS, and lack of 
visual requirements make this assessment technique more popular in the clinical setting. 
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In addition, pain management strategies are often prescribed based on the NRS value the 
patient reports. Providers may write prescriptions for certain medications or opioids for 
pain management if the NRS level is above 3 or 4, with incremental dosage increase, 
depending on patient NRS score (van Dijk et al., 2014).  
Disadvantages. Both pain scales typically lack consideration of patient age or 
cognitive level, in which developmental function may influence pain scores (Nagelhout 
& Plaus, 2014).  Additionally, they lack depth of determining the quality of the pain and 
other possible exacerbating or associated factors that could affect pain (Nagelhout & 
Plaus, 2014). Patient understanding of rating pain on the scale is crucial, and may be 
influenced by patient culture, pain history, or tolerance to pain.  
 Postoperative Pain after Thoracic Surgery. Thoracic surgery is inclusive of 
surgical procedures involving the thoracic cage, and can include: airway, esophagus, 
lungs, diaphragm, chest wall, and heart. A wide variety of factors cause pain after 
thoracic surgery, including: tissue retraction, vein harvesting, artery dissection, along 
with prolonged surgery and sustained uncomfortable position throughout the procedure 
(Bignami et al., 2018). In addition, inflammation of tissue triggered by the trauma 
induced by intended surgical bone fractures and dislocations can create a significant 
amount of pain (Bignami et al., 2018). Along with the multiple painful factors of surgery 
itself, patients typically leave the operating room with drainage catheters, sternotomy 
and/or thoracotomy incisions, central venous access devices and more, which can have a 
large impact on pain scores (Bignami et al., 2018).  
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Reported postoperative pain following thoracic surgery is often higher in the first 
two days after surgery and typically reported as more intense in young, female 
populations (Bignami et al., 2018). Multiple guidelines support positive patient outcomes 
when patients participate in early ambulation and advance diets within hours to a day 
after the surgical procedure (Sarin et al., 2016). Coughing, deep breathing, eating and 
increasing activity level can contribute to pain and result in patient apprehension to 
continue activity, but can speed overall recovery rates, lessen duration of pain and 
minimize its consequences (Sarin et al., 2016). 
Studies of postoperative pain after thoracic surgery. Guastella et al. (2011) 
conducted a prospective study of 54 patients to evaluate pain following thoracic surgery. 
The study evaluated patients that underwent a thoracotomy with a single surgical team 
using standardized approaches for the surgery and analgesic management. The population 
reported NRS scores < 3 in the first 72 hours after surgery when using a pain regimen 
protocol. Two months after surgery, 49 patients (91%) reported continued thoracic pain 
and of those, 12 patients were still using analgesics. At 6 months, 7 patients were 
excluded from the study due to lack of follow up, and 38 of 42, or 90.4%, of patients 
reported persistent postoperative pain. 30.9% of those patients reported still using 
analgesics, and 2 patients transitioned to antidepressants for pain management (Guastella 
et al., 2011). At the six-month evaluation, three patients were additionally lost in follow 
up due to difficulties in correctly evaluating pain, leaving a total of 35 patients remaining 
for further evaluation for chronic postoperative pain. Of this group of patients, the mean 
NRS score was 3.93 ± 2.3, and of the 13 patients still utilizing pain treatment, NRS was 
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6.16 ± 2.1. Spontaneous pain at incision or surgical area was reported by 86% of patients, 
most commonly referred to as throbbing, shock-like and wrenching pain (Guastella et al., 
2011).  
In a prospective observational study by Wang et al., (2017), 300 patients were 
evaluated for pain intensity following thoracic surgery in the immediate first seven days 
of surgery and then in intervals, up to 6 months after surgery. The study reported that in 
the first 2 days after surgery, using the NRS, approximately 65% of patients reported 
moderate to severe pain with movement, which decreased to 30% of patients by 
postoperative days (PTD) 4-7 (Wang et al., 2017). Pain intensity with coughing was also 
reported as moderate to severe in 85% of patients PTD 1-2, with a decrease in 65% of 
moderate to severe by PTD 4-7 (Wang et al., 2017). In patients reevaluated at six months 
after their surgery, 48.9% reported continued, chronic pain (Wang et al., 2017). The 
authors also concluded that patients were more reluctant to request pain management 
when desired, especially if not properly educated regarding the importance of pain 
management or were not aggressive in treating pain before severe levels occurred (Wang 
et al., 2017).  
Pharmacological Options  
 Current clinical guidelines for the management of postoperative pain have evolved 
over recent years in response to the reported high levels of pain after surgical procedures. 
In the past few decades, providers have relied heavily on the use of medications that hold 
a shorter half-life, thus providing a shorter duration of action (Kharasch, 2011). This can 
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lead to uncontrolled pain after surgery, which may become difficult to manage once it 
escalates to a higher level.  
With input from the American Society of Anesthesiologists (ASA), The American 
Pain Society created an interdisciplinary panel of experts in pain management to decipher 
and promote evidenced based, safe, postoperative pain management in adults and 
children (Chou et al., 2016). As part of the guideline process, the expert panel review 
conducted a systematic review, including a review of the literature to evaluate different 
aspects of pain management in relation to various interventions and management 
strategies of postoperative pain. Chou et al., (2016) formulated recommendations based 
on their findings that addressed different aspects of postoperative pain. The 
recommendations include: preoperative patient education, perioperative pain 
management techniques and planning, multimodal approach of pharmacological and 
nonpharmacological treatment modalities, organizational policies and the transition of 
patient care to an outpatient setting (Chou et al., 2016). The foundation of optimal 
postoperative pain management includes the premise that treatment of postoperative pain 
is initiated in the preoperative phase with patient centered assessments, and plan that 
focuses on the individual and proposed surgical procedure (Chou et al., 2016).  
 Patient Controlled Analgesia. Patient controlled analgesia (PCA) is widely used in 
postoperative management of pain. The use of this method allows for patients to press a 
button, programmed by a pump, and the patient is able to deliver a dose of pain 
medication when they feel pain and wish to seek relief.  PCA pumps are programmed by 
the provider and control parameters are set, including bolus dose, lockout interval, dose 
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limits and loading dose of the medication upon establishment of the pump (Kuo, Chang, 
Juan, Hsu, Chan & Tsou, 2018). If deemed necessary, the provider can also program the 
PCA to deliver a continuous infusion of the opioid in addition to the controlled doses the 
patient can receive.  The PCA maintains a log of records of all events pertaining to the 
therapy, including amount of patient demand and amount of opioid delivered over a 
period of time. Patients utilize the PCA in the first few hours or days after surgery and are 
commonly switched to oral pain medication. Although a highly effective method of 
providing pain relief after surgery, it also carries risks, including: respiratory depression, 
respiratory arrest or even death, if not properly and closely monitored (Kharasch, 2011).  
Neuraxial Analgesia. Central neuraxial anesthesia is the placement of anesthetic 
solution onto, or adjacent to, the spinal cord, and includes spinal and epidural anesthesia 
(Nagelhout & Plaus, 2014). Due to the location of the desired sensory blockade in 
thoracic surgery, spinal injections are contraindicated, but epidurals can be utilized 
(Nagelhout & Plaus, 2014). An epidural injection can be performed with an attached 
catheter that can be used for multiple doses of anesthetics or pain medication, throughout 
a procedure, and later in the postoperative phase (Nagelhout & Plaus, 2014). Multiple 
advantages of epidural catheters exist, such as allowing the patient to use a patient 
controlled epidural analgesia (PCEA) to deliver medications by the epidural catheter and 
decreased risk of: venous thrombosis, myocardial infarction, respiratory depression and 
pneumonia (Chou et al., 2016).  
Chou et al. (2016) further found that in the treatment of thoracic perioperative 
pain, current guidelines recommend neuraxial analgesia, such as epidural anesthesia, 
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especially for patients at risk for pulmonary or cardiac complications. Chou et al. (2016) 
suggested that neuraxial analgesia with local anesthetics, is associated with decreased 
requirements for acute pain management, also referred by rescue analgesia.  
Comparison. In a meta-analysis of randomized control trials conducted by Wu et 
al.,  (2005) PCEA provided significantly superior postoperative pain control compared to 
PCA, for up to three days after surgery. The meta-analysis included 50 articles that 
compared the use of PCA versus PCEA for pain control in postoperative pain 
management (Wu et al., 2005). The study then compared the type of surgery and pain 
scores. According to Wu et al. (2005), average pain scores for patients with a PCEA were 
1.6 ± 1.5 of 1,157 patients, compared to PCA scores 2.7 ± 1.8 in 1,139 patients. The 
authors concluded that due to the ability of PCEA management to block nociceptive input 
to the central nervous system with the addition of opioids, compared to intravenous 
administration allowed for greater pain control (Wu et al., 2005).  Unfortunately, 
neuraxial anesthesia is not always an option due to patient refusal, inadequate provider 
skill, unsuccessful insertion attempts, or other technical or medical reasons. A few of the 
main contraindications of neuraxial anesthesia include mitral or aortic stenosis and 
preoperative anticoagulation regimens, which are both highly typical of a patient 
planning to undergo cardiothoracic surgery (Nagelhout & Plaus, 2014). 
Oral and Intravenous Opioids. Systemic analgesics and adjunctive medications 
are the main alternative to invasive techniques and continue as the main approach for 
pain management following intraoperative procedures (Gottschalk, Cohen, Yang & 
Ochroch, 2006). Opioids are still currently the main option for treatment of pain in all 
17 
 
 
phases of surgery, especially in the postoperative phase. Intravenous administration is 
typically utilized intraoperatively and then converted to oral administration once the 
patient is able to eat and drink fluids. Unfortunately, opioids carry a significant risk of 
causing dependence, addiction and respiratory depression, especially in higher doses. To 
prevent these side effects, adjuvant medications, such as Nonsteroidal Anti-inflammatory 
Drugs (NSAIDs), acetaminophen, gabapentin and tramadol are often considered 
(Gottschalk et al., 2006).  
Consequences of Postoperative Pain 
 Extended periods of postoperative pain can have significant consequences to 
patient’s health and recovery physiologically and psychologically. In the initial 
postoperative phase, pain is considered acute, but if prolonged, it can become chronic 
pain.  
 Acute Postoperative Pain. Extended periods of unrelieved pain can cause a 
negative effect on every major organ within the human body. With regard to the 
endocrine system, pituitary-adrenal activation can occur and lead to impaired 
immunological function and increase the risk of postoperative wound infection 
(Hutchinson, 2007). This infection risk is noted as even higher than original surgical risk 
of infection (Hutchinson, 2007). Pain can increase sympathetic response that can cause 
negative effects to the cardiovascular, renal and gastrointestinal systems, which lead to 
vasoconstriction and reduced blood flow to vital organs. In addition, pain can cause 
patient apprehension related to ambulation, deep breathing exercises, nutrition, which are 
often important elements in recovery of the surgical patient (Hutchinson, 2007).  
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 Patients that receive adequate pain management enhance their ability to 
participate in early mobility, and thus lessen the risks of urinary retention, ileus, and 
myocardial infarction (Glowacki, 2015). In addition, with proper pain management, sleep 
deprivation which can later lead to postoperative fatigue and delirium, can be avoided. 
Prevention of postoperative fatigue can also enhance mobility after surgery, and reduce 
the amount of pulmonary complications (Glowacki, 2015).  
Adverse Complications. As a result of the multiple complications listed, a wide 
range of potential adverse events can occur, such as deep vein thrombosis, pneumonia, 
wound infection, pulmonary embolism, myocardial infarction, and chronic pain 
syndrome (Hutchinson, 2007). Prolonged illnesses or complications can lead to mental 
health issues such as stress, depression, and anxiety (Hutchinson, 2007). Furthermore, 
beyond the medical issues, poor pain management can contribute to increased healthcare 
costs for the patient and provider. Prolonged hospital courses, readmissions and patient 
dissatisfaction are also factors that add to poor outcomes after surgery (Hutchinson, 
2007).  
According to Glowacki (2015), five dimensions contribute to pain management: 
physiological, sensory, affective, cognitive, and sociocultural components. Each 
dimension is crucial for patient evaluation with regard to management of acute pain. 
Aggressive pain control in the acute phases is still an underutilized technique, and despite 
guidelines and studies published to evaluate pain management, patients are still left 
somewhat unsatisfied.  Glowacki (2015) infers that if all five dimensions of pain 
management are addressed, adverse complications of acute pain can be avoided.  
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 Chronic Postoperative Pain. According to the International Association for the 
Study of Pain (2002), chronic pain is defined as pain that recurs or persists within range 
beyond the healed incision site, at least two months after the surgical procedure. This 
pain can lead to immobility of surgical site and surrounding areas due to exacerbation of 
pain. Patients with suboptimal pain management in the acute phase after surgery are at 
risk of developing persistent pain which can then progress to chronic pain. This can lead 
to further and increased opioid requirements, tolerance and possible opioid addiction. 
 Chronic Pain Following Cardiac Surgery.  In a prospective cohort study by van 
Gulik et al. (2011), 146 patients were evaluated following cardiac surgery via 
sternotomy. In all patients, anesthesia was standardized during induction and 
maintenance phases of the anesthetic approach. Pain was managed in the postoperative 
phase of surgery with a continuous infusion of morphine, in combination with 
acetaminophen (Gulik et al., 2011). Pain scores were evaluated during the initial seven 
days following the surgery and 10-12 months after the surgery by telephone interview by 
questionnaire and evaluation of NRS score.  At 10-12 months following the surgery, 35% 
reported the sensation of chronic thoracic pain and 29.2% reported severe pain (Gulik et 
al., 2011). Additionally, regardless of type of thoracic procedure, such as Coronary 
Artery Bypass Graft (CABG), valve surgery, aortic and CABG combined with valve 
surgery, the incidence of chronic pain was the same among each surgery (van Gulik et al., 
2011). Of the chronic pain sufferers, 14.3% reported minor or major pain that had 
influence on their daily life and had to stop working or reduce their work hours due to the 
pain (van Gulik et al., 2011). Van Gulik et al. (2011) did not find a difference in chronic 
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pain scores of those patients that had previously undergone a sternotomy prior to the 
surgery being evaluated. Van Gulik et al. (2011) determined that several characteristics 
correlated with the development of chronic pain one year after cardiac surgery. These 
characteristics included: non-elective surgery, resternotomy shortly after the original 
surgery, female gender and severe pain on the third postoperative day (Gulik et al., 2011).  
A prospective study conducted by Bayman, Parekh, Keech, Selte, and Brennan 
(2017) evaluated 99 patients at 3 and 6 months after thoracic surgery to evaluate for 
chronic pain. Two surgical methods were compared: thoracotomy and video assisted 
thorascopic surgery (VATS). Researchers found that chronic pain values measured at 3 
and 6 months postoperatively by use of the NRS were similar among the two. The goal of 
the study was to detect predictors of chronic pain and to determine if acute pain played a 
significant role in the development of postoperative chronic pain. In the immediate 
postoperative phase, pain was managed with patient-controlled analgesia and measured in 
morphine equivalents. Researchers evaluated NRS scores in the first three days after 
surgery, in addition to the presence and amount of chest tubes each patient had. There 
were no differences in the average NRS in the preoperative or 3-day postoperative phase 
in either surgical groups.  Bayman et al. (2017), found that the incidence of chronic pain 
in their study at 3 months after either surgery was prevalent in 34% of patients, and at 6 
months, was 27%. At 3 months, 16% of patients reported pain that limited daily 
activities, and at 6 months, 8.2% reported continued limitations (Bayman et al., 2017).  
The study linked the incidence of a higher severity of pain during the first three days 
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postoperatively to a higher incidence of chronic pain lasting 6 months after the initial 
surgery.  
Methadone 
 Methadone was introduced in 1940 as a synthetic opioid and contains the same 
potency and similar side effects as morphine when given intravenously (Barbosa Neto, et 
al., 2014). A close relationship between stereochemical structure and potency of opioids 
exists between naturally occurring morphine and synthetic methadone (Nagelhout & 
Plaus, 2014). Methadone is considered a diphenylheptane derivative and holds a slightly 
similar molecular structure to morphine, comprised of two of the five natural ring 
structures seen in morphine (Nagelhout & Plaus, 2014).  Methadone and morphine both 
affect the same pain receptors, mu, kappa and delta (Nagelhout & Plaus, 2014). 
Structurally, methadone is a racemic mixture of d-isomer (S-methadone) and l-isomer (R-
methadone), which each component allowing for a different mechanism of pain control 
(Nagelhout & Plaus, 2014).  The d-isomer allows antagonization of the NMDA receptor, 
inhibiting uptake of norepinephrine and serotonin, which contributes to treatment of 
neuropathic pain and prevention of opioid tolerance (Nagelhout & Plaus, 2014).  The l-
isomer binds to opioid receptors, therefore treating pain (Nagelhout & Plaus, 2014).  
Methadone can be administered via oral, intravenous, subcutaneous, and rectal route 
(Nagelhout & Plaus, 2014).  When administered orally, methadone’s peak effect is 30-60 
minutes, and intravenously, effects are seen within 15-20 minutes (Nagelhout & Plaus, 
2014).   
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In current practice, methadone is primarily used for treatment of chronic pain, 
opioid abstinence syndrome, and treatment of heroin addiction (Nagelhout & Plaus, 
2014). As compared to other opioids, it produces less euphoria and has a longer half-life, 
which allows for less frequent dosing requirements (Nagelhout & Plaus, 2014). The 
elimination half-life, referred by the amount of time for half of the drug to be eliminated 
from the body, can range greatly among individuals, from 8-90 hours (Barbosa Neto, et 
al., 2014). This allows an extended period of duration of action from 4-8 hours (Barbosa 
Neto, et al., 2014). The prolongation of the drug and drug effect is partly due to the 
extensive protein binding it has within the body, which allows for a slow release and 
delayed metabolization of the drug (Nagelhout & Plaus, 2014). In addition, methadone 
has a high bioavailability and is not associated with active metabolites (Nagelhout & 
Plaus, 2014).  
Methadone: Role in Postoperative Pain Management 
Multilevel Thoracolumbar Spine Surgery. The use of methadone in the surgical 
population has been widely studied in various types of surgeries, such as spinal surgery 
and total hip arthroplasty. In recent studies, methadone has been compared to other, 
shorter acting drugs and evaluated for efficacy and pain control in the postoperative 
phase. In a randomized control trial conducted by Gottschalk, Durieux, and Nemergut 
(2011), a single dose of intraoperative methadone was compared to a continuous infusion 
of sufentanil, a short acting opioid, in patients undergoing lumbar spinal surgery. The 
population included 29 patients that underwent multilevel thoracolumbar spine surgery. 
Pain was reassessed at 24, 48, and 72 hours after surgery (Gottschalk et al., 2011).  
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Patient demographics in each of the groups were similar with respect to age, sex, body 
weight and height, body mass index and American Society of Anesthesiologists (ASA) 
status.  
Gottschalk et al., (2011), found that the preoperative opioid use, preoperative pain 
scores, length of surgery, time to extubation, estimated blood loss, and intraoperative 
crystalloid or colloid requirements were comparable between both groups. Pain after 
surgery was reported to be significantly less and more statistically significant 48 hours 
after extubation in the methadone group. To effectively compare the two medications, 
dosages were converted to morphine equivalents. In the sufentanil versus methadone 
group, at 48 hours postoperative, morphine equivalents were measured at 63mg versus 25 
mg, and at 72 hours after surgery 34 mg versus 15 mg (Gottschalk et al., 2011). In 
addition to these findings, the study proved that pain scores were approximately 50% 
lower in the methadone group versus the sufentanil group at 48 hours after surgery 
(Gottschalk et al., 2011). Gottschalk et al., (2011), inferred that perioperative use of one 
single bolus of methadone improves postoperative pain control and allows a reduction of 
additional opioid requirements in patients undergoing complex spine surgery.  
Pacreau, Candil, Carazo and Galinski (2012) evaluated the intraoperative use of 
methadone versus methadone mixed with ketamine on postoperative opioid consumption 
in 22 patients undergoing multilevel lumbar arthrodesis. The MK group, methadone 
mixed with ketamine, received a pre-incisional bolus of intravenous racemic ketamine 
0.5mg/kg, followed by an infusion of 2.5mg/kg/min of methadone. The patients in the 
control group, ME group, received a bolus of saline and an infusion of 2.5mg/kg/min of 
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methadone. Postoperatively at 24-48 hours, each patient group was given a PCA 
administering 1 ml bolus, with a lockout of 10 minutes and maximum of 3 boluses per 
hour. In the MK group, the PCA contained 0.25mg of methadone plus 0.5mg of ketamine 
and the ME group contained 0.5mg of methadone.  
 Strict methods and protocols were held for induction of anesthesia and held 
throughout the patients’ operative time. Postoperatively, the NRS value was evaluated 
and recorded, and 2mg of methadone boluses were administered every 15 minutes until 
the NRS scale was equal or less than 3, and then the PCA was started. A blinded team 
member recorded the NRS value at rest and at movement, at 24 and 48 hours. Also 
recorded was the amount of consumption of opioid delivered, the demanded doses and 
the delivery to demand ratio.  
Pacreau et al. (2012) found that the difference between the consumption of 
methadone at 24 hours by PCA was an average of 15mg for the ME group versus 3.4mg 
for the MK group. At mobilization, pain average for MK group was 4.5 and for ME 
group 6 on the NRS scale (Pacreau et al., 2012). Pacreau et al. (2012) found that while 
methadone is an effective drug for postoperative pain, the use of methadone with an 
adjunctive treatment for pain provided a significant level of pain control, as evidenced by 
lower pain scores and decreased opioid intake.  
Total Hip Arthroplasty. Barbosa Neto et al., (2014) conducted a randomized, 
double blind, controlled, parallel group study comparing the pain management of 34 
patients that underwent a Total Hip Arthroplasty (THA) and received postoperative 
morphine PCA versus methadone PCA. Surgery was performed under spinal anesthesia 
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by the same surgical team using similar surgical approaches in each of the groups. Drug 
potency ratio was 1:1 to compare and convert total morphine to methadone consumption. 
During the postoperative phase, patients were assessed five times to collect information 
regarding pain intensity, side effects, and analgesic consumption (Barbosa Neto et al., 
2014). Reassessments of pain were scheduled on arrival to Post-Anesthesia Care Unit 
(PACU), and then at 6, 12, 18 and 24 hours after PCA installation (Barbosa Neto et al., 
2014). Based on data collected, it was determined that opioid consumption at 24 hours 
postoperative was significantly lower in the methadone group than the morphine (37 mg 
of methadone use versus 55.6 mg of morphine) (Barbosa Neto et al., 2014). Barbosa Neto 
et al., (2014) concluded that methadone PCA presented as a favorable drug in the 
selection of pain management in treating postoperative pain in major surgeries. 
Conclusion 
 Methadone is a drug that is often stigmatized due to its use in the treatment of 
substance abuse. Unfortunately, advantageous benefits of the drug are limited in the 
surgical setting. Methadone is a drug that can offer substantial pain management in the 
postoperative setting for a wide variety of patients. Although methadone can have 
varying lengths of duration in individuals, it can offer longer pain management than most 
opioids used in current practice. For this reason, it can potentially decrease the amount of 
opioid intake and length of time patients are in pain after surgery. As previously noted, 
the importance of management of acute postoperative pain can be crucial in preventing 
severe side effects, such as: increased length of hospital stay, poor healing, increased 
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comorbidities, the development of chronic pain, and much more. Methadone should be 
evaluated for its potential use in the surgical setting in cardiac and thoracic surgeries.  
Next, the theoretical framework utilized in this systematic review will be discussed.  
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Theoretical Framework 
 Healthcare is rapidly growing and frequently changing practice, based on 
evidence-based data. In order to enhance the delivery of healthcare that Certified 
Registered Nurse Anesthetists (CRNAs) provide, empirical evidence is examined, proven 
and converted to standards and guidelines, and placed into practice. Therefore, extracting 
and evaluating the most relevant evidence available in systematic reviews and meta 
analyses is required to examine strength and validity.  The use of The Preferred 
Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement 
supports the methods used to search and evaluate the articles used in this systematic 
review. The PRISMA guidelines were used to improve the quality of data reporting and 
in the assessment of strengths and weaknesses of each article in the review. 
The PRISMA statement (Appendix A) consists of an evidence-based checklist of 
27 items that are considered crucial for accurately reporting and evaluating a research 
study (Daley, 2016). The checklist is divided into categories of sections found in standard 
research, including: title, abstract, introduction, methods, data collection processes, 
results, and discussion, bias reporting, limitations, with an additional section providing 
information regarding funding. After these considerations are met, the articles will then 
be further investigated for eligibility and omitted if unable to meet previously established 
inclusion and exclusion criteria. The remaining articles will be utilized for data synthesis 
and recommendations.  
The PRISMA guideline also incorporates a flow diagram that can be used for 
additional organization of the literature review. The flow diagram allows for transparency 
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regarding article selection of inclusion and exclusion criteria. It also allows for guidance 
among reporting information regarding final number of studies utilized throughout the 
systematic review.  In addition to the PRISMA checklist and flowchart, the consolidated 
standards of reporting trials framework (CONSORT) are also used (CONSORT, 2011). 
CONSORT was used to further evaluate and determine quality of the randomized control 
trials utilized in this systematic review. CONSORT was designed and utilized to assess 
randomized control trials to evaluate strengths, weaknesses and any limitations to be 
included, in addition to any research bias.  
 Next, the methods utilized in this systematic review will be discussed.  
 
 
 
 
 
 
 
 
 
 
  
29 
 
 
Methods 
Purpose of Study 
The purpose of this paper is to conduct a systematic review to determine if 
intraoperative methadone administration will affect postoperative pain after 
cardiothoracic and thoracic surgery as evidenced by pain score levels and documented 
postoperative opioid use. 
Inclusion and Exclusion Criteria 
 Inclusion criteria will include: randomized control trials pertaining to subjects 18 
years or older; studies evaluating the administration of methadone in a cardiac or thoracic 
surgery, and evaluation of pain scores postoperatively using pain scales. Exclusion 
criteria: research before 2004; non-English articles, non-human subjects, and pain 
management articles not related to methadone use.  
Search Strategy 
 The literature search was performed using CINAHL and PubMed databases. The 
initial search was generalized and conducted by using the keyword “methadone” within 
each database. A total of 5,120 were found utilizing CINAHL and an additional 15,610 
articles were located within PubMed. The search was narrowed by the addition of a 
second keyword: “surgery.” The results from both CINAHL and PubMed were 
drastically reduced to 53 and 542 items, respectively. A final filter was placed to limit the 
search of literature between the years 2004 and 2019, specifically related to cardiac or 
thoracic surgery, in addition to filtering the articles to those reporting on adult, human 
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subjects only, and written in English.  The final search resulted in 23 articles from 
CINAHL and 80 from PubMed. 
Data Collection 
 Subsequent to the collection of articles, the randomized control trials (RCT) were 
reviewed and relevant data was extracted for further analysis. Data was collected from 
randomized clinical trials in which methadone was given to a portion of the sample 
population during any part of the operative phase, and later compared opioid use from 
those who received the methadone versus the control group. As an effort to analyze the 
influence of methadone on NRS scores in addition to other variables measured in the 
randomized control trials, a table was created for data collection and comparison of each 
of the studies. The first table was designed to compare basic, demographic data regarding 
the groups of patients studied. This included: author, year, number of patients in the 
study, ages of participants, gender, ASA score, procedure performed, duration of 
procedure, and allocation of participants into the control and interventional groups (Table 
1). 
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Table 1 
Data Collection Sheet #1 
 
 A second table was created to organize study variables that may have a possible 
influence over pain scores within each of the trials. Data Collection table # 2 included 
author and year, agents used for induction of anesthesia, agents used for the maintenance 
of anesthesia, timing of administration of the study drug, intraoperative methadone dose 
administered, intraoperative interventional dose administered, rescue pain medication and 
dosing used in recovery after surgery, time to first analgesic in each group (Appendix D).  
Critical Appraisal  
 The critical appraisal tool used to evaluate the randomized control trials in this 
review was The Consolidated Standards of Reporting Trials, or CONSORT method 
(Appendix B). The method is a 25-item checklist, utilized to distinguish strengths, 
weaknesses, limitations and biases of each of the trials. This includes trial design, 
 Author, Year #Pt  Ages 
(yr) 
M/F ASA Procedure Duration 
(min) 
methadone 
Group 
Control Group Route 
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participant eligibility and criteria, setting and location of data collection, interventions 
administered, outcome measures, sample size determination, randomization, blinding, 
and funding.  
 A flow diagram designed by CONSORT, illustrated in figure 1 on the next page, 
was utilized to assess and determine strength and weaknesses of the randomized control 
trial. The diagram concentrates on sample size, randomization, allocation of participants 
and those participants lost during follow up and analysis. The flow diagram was 
completed for each randomized control trial involved in this systematic review.  
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Figure 1. CONSORT Flow Diagram (CONSORT, 2010) 
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To best organize the data from the CONSORT findings, a table was created. This 
table includes: author and year, study type, consent and funding, inclusion and exclusion 
criteria, randomization, attrition, blinding methods, strengths and limitations of each 
study (Appendix E). These categories were chosen based on guidelines from both 
CONSORT and PRISMA checklists and flow diagrams. This method allowed for a more 
concise and valuable assessment tool. 
Data Synthesis and Cross Study Analysis  
 The data collection tools that were utilized to derive information from the 
randomized control trials allowed synthesis and analysis of the data comparatively across 
each of the studies. A cross study analysis was performed to evaluate the length of 
surgical duration, time to extubation, time to when the patient needed their first rescue 
analgesic, the overall NRS scores in the first 24 hours, the extended NRS scores if 
provided in the study, other and adverse events. The data was transcribed into the table 
below (Table 2), and the results later described in this paper.  
Table 2 
Cross Study Analysis 
Author, 
Year 
Surgery 
Time 
(hr) 
Time to 
extubation 
(hr) 
Time to 
1st 
rescue 
analgesic 
(hr) 
NRS in 
first 24 
hrs 
NRS 
extended 
period 
Other Adverse 
Events  
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 Next, the results section will be discussed.  
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Results 
 The PRISMA flow diagram (Appendix E), accompanied by inclusion and 
exclusion criteria previously mentioned, were used to eliminate and select applicable 
articles appropriate for this systematic review. After the search for applicable articles and 
elimination of duplicate articles, a total of 28 articles remained for review. The abstracts 
of these articles were evaluated for evidence of exclusion criteria. This process 
eliminated a total of 16 articles. The remaining 12 articles were reviewed thoroughly for 
their relevance and were selected for the systematic review based on both inclusion and 
exclusion criteria. The final elimination process excluded 7 articles, leaving 5 articles for 
inclusion in the systematic review. The five remaining articles were randomized control 
trials that met the inclusion criteria and were used in the creation of this systematic 
review. The following information is a summary of results obtained from the data 
collected.  
Cardiac Surgery 
 The randomized control trial conducted by Carvalho, Sebold, Calegari, de 
Oliveria and Schuelter-Trevisol (2011), included 104 patients submitted to coronary 
bypass graft surgery without cardiopulmonary bypass, age ranging from 53-73 years old 
and ASA III-IV. The study reported 63% of patients were males, and additionally 
reported no proportional difference between groups regarding sex (p-value 0.534) 
(Carvalho et al., 2011). The mean duration of the surgery between the two groups ranged 
from 187.2-201.1 minutes, with the methadone group mean slightly longer than the 
morphine group. Four participants were excluded, two from each group for reasons of: 
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death, prolonged intubation lasting more than 12 hours and reintubation. This changed 
the final number of participants to 100. Induction of anesthesia was performed with 
sufentanil 0.5 mcg/kg, with 10 mcg boluses as needed, etomidate 0.2mg/kg and 
rocuronium 0.1mg/kg. Maintenance of anesthesia was achieved with sufentanil 0.25-0.5 
mcg/kg/hr and sevoflurane 0.5-1 MAC.  Patients remained intubated at the end of the 
procedure upon arrival to ICU. Providers in the ICU were blinded to the group each 
patient was assigned to. Patients in both groups were given intravenous dipyrone 1 gram 
every six hours continuously. If patient complained of moderate or severe pain, 
intravenous morphine 0.03 mg/kg was administered, with a limit of 0.1 mg/kg in a four-
hour period. If patient complained of nausea or vomiting, metoclopramide hydrochloride 
10 mg was administered. Duration of anesthesia, number of doses and types of analgesics 
and antiemetics were recorded during the postoperative time, along with adverse 
reactions, such as nausea, vomiting, and respiratory depression. Respiratory depression 
was defined as a rate of less than 8 respirations per minute, and/or the requirement of re-
intubation. These reactions were observed by the ICU professionals and/or research team 
throughout the patient’s ICU admission.  
Numerical pain scores were recorded at 12, 24 and 36 hours postoperatively. In 
addition, blinded researchers recorded the first analgesic administration and extubation 
time. The numerical pain scale was used, with ranges of 0-3 considered mild pain, 4-7 
moderate pain and 8-10 severe pain. Mean and standard deviation of pain scores were 
represented in the study at 12, 24 and 36 hours for both groups. At 12 hours, the 
morphine group pain score mean was 4.7 ± 2.6 and methadone was 4.2 ± 2.7. At 24 
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hours, morphine scores were 2.9 ± 2.6 and methadone 1.9 ± 2.2, and at 36 hours 
morphine 0.5 ± 1.1 and methadone 0.5 ± 1.2. The time to first analgesic in minutes was 
269.4 ± 252.9 for the morphine group; the methadone group was shorter, at 149.9 ± 
178.5. Although this time was shorter, 43% of the morphine group required additional 
postoperative morphine versus 29% of the methadone group. The morphine group had 
19% adverse events versus the methadone group at 16%. In addition, 27% of the 
morphine group required metoclopramide for nausea or vomiting, versus the 18% of the 
methadone group. Respiratory failure in each group was similar, 1% of morphine and 2% 
of methadone.  
Patients were evaluated for overall satisfaction regarding pain analgesia and 
occurrence of adverse events in 36 hours. The morphine group reported a 28% success 
rate of satisfaction and the methadone group reported 44% success rate. The study 
utilized the Kolmogorov-Smirnov test to analyze quantitative, normally distributed data, 
and the Student’s t-test to compare means. In non-normal distribution, non-parametric 
statistics were used applying the Wilcoxon-Mann-Whitney U test. The Pearson chi square 
test was also used to verify the association between the variables of interest.  
Using the CONSORT framework, a flow diagram was presented to assess sample 
size, eligibility, exclusion criteria, randomization and attrition of the participants in the 
study (Appendix H-1).  The study did not measure level of sedation of patients, which 
could have had an impact on the patient’s level of pain. In addition, pain score medians 
were recorded at 12, 24 and 36 hours, but information regarding amount of patient 
assessments, or evaluation of pain scores were not reported. The study also reported 
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respiratory failure in each group but did not elaborate on the cause or treatment the 
patient received. The study reported three patients were excluded prior to initiation of the 
study due to prolonged extubation time and reintubation. It is unclear by the study if it 
had an effect on pain scores on either group.  
The trial conducted by Udelsman et al. (2011) a group of patients scheduled for 
cardiac surgery with cardiac bypass, were divided into three groups and given 
methadone, morphine or a placebo, at induction of anesthesia. The study included 55 
patients, ages ranging from 42-72, and ASA III-IV. The study excluded patients on 
antidepressants, known allergy to study drugs, chronic opioid use, and patients that 
remained intubated longer than 24 hours after surgery. Information regarding initial pool 
of patients nor details about the number, nor reason for exclusion of patients was 
included. Patients were randomly and double blinded into three groups: methadone, 
morphine and control. Induction on all three groups was performed with sufentanil 0.1 
mcg/kg, midazolam 0.1 mg/kg and pancuronium 0.1 mg/kg. After induction, each blinded 
group received a dose of either 20 mg of morphine, 20 mg of methadone or 2 mL of 
normal saline. Anesthesia was maintained with sufentanil 0.01 mcg/kg/min, isoflurane 
0.5% and when clinically indicated, pancuronium 0.03 mg/kg. Patients were transferred 
to the intensive care unit and continually monitored for pain. After extubation, morphine 
0.03 mg/kg was administered throughout the postoperative period when necessary.  
The study evaluated duration of anesthesia, time until extubation, time until 
administration of the first dose of analgesic, number of doses of analgesics required and 
prevalence of nausea or vomiting. Time to extubation for each group were as follows: 
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methadone 430.83 +/ 304.35, morphine 358.95 ± 179.15 and control 341.67 ± 144.41. In 
addition, the time to first analgesic for each group were as follows: methadone 855.17 ± 
593.39, morphine 625.53 ± 525.23 and control 507.56 ± 413.04. The study reported the 
number of patients requiring analgesics in the first 24 hours was lowest in the methadone 
group and significantly higher in the control group. Patients requiring analgesic in the 
first 24 hours was reported in 10 of 18 patients in the methadone group, with a median 
NRS score of 0.5 ± 0.71. The authors of this study reported the number of required doses 
of pain medication were 0.89 ± 1.02. Comparatively, 14 of the 19 patients in the 
morphine group required 1.32 ± 1.05 doses with a median NRS of 1.84 ± 1.38. The 
control group required 2.39 ± 0.85 doses with median NRS 2.83 ± 2.18. The number of 
patients reporting postoperative nausea or vomiting (PONV) were 1 of 18 patients in the 
methadone group, 6 of 19 patients in the morphine group and 9 of 18 in the control 
group.  
A CONSORT flow diagram (Appendix H-2) was used to report data regarding 
sample selection, allocation and attrition. The researchers did not report the initial 
number of participants assessed for the study. Although the researchers did mention 
patients that were intubated longer than 24 hours in the postoperative period were 
excluded from the study, it did not report the number of participants that were excluded 
for this reason. A total of 55 patients were included in the study.  
Murphy et al. (2015) conducted a randomized control trial of patients undergoing 
elective cardiac surgery with cardiopulmonary bypass that were randomized to receive 
intravenous methadone or fentanyl intraoperatively. The study included 156 patients, age 
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ranges 54-75, both groups with a higher percentage of male participants. Height and 
weight of each group was within a similar range, and ASA scores were III-IV. Four 
options for surgery existed: coronary artery bypass graft (CABG), valve surgery, CABG 
with valve surgery or atrial septal defect repair. The induction and maintenance of 
anesthesia was treated the same regardless of surgery performed. 
Patients were randomized by a computer-generated randomization code to receive 
either methadone or fentanyl intraoperatively. The study opioid was prepared by the 
operating room pharmacy in identical appearing clear plastic bags, and doses were 
reported as equipotent. Induction of anesthesia was induced with midazolam 2-4 mg, 
propofol 20-100 mg titrated to loss of consciousness, and rocuronium 0.6-0.8 mg/kg.  At 
the time of the induction, one half of the study drug was administered via an infusion 
pump over 5 minutes. The remainder of the drug, methadone 0.15 mg/kg or fentanyl 6 
mcg/kg, was infused over the following two hours.  Maintenance of anesthesia was with 
sevoflurane 0.4-3%, titrated to Bispectral Index values of 40-60 and to mean arterial 
pressure within 20% of baseline value. During rewarming phase of the surgery, 
midazolam 5 mg was administered, and during chest closure an infusion of propofol 10-
50 mcg/kg/min was started and continued until ventilatory weaning in the ICU. Time of 
ventilatory weaning in the ICU was comparable of both groups, methadone group at 
mean of 4.75 hours and fentanyl group of 4.5 hours. Extubation time was 6.5 and 6.0 
hours, respectively. The study did note that the methadone group did have a quicker ICU 
discharge to the surgical ward, a mean of 30.5 hours, versus the fentanyl group at 47.1 
hours.  
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Patients were assessed for pain at rest and with coughing by nurses in the ICU 
after discontinuation of the propofol infusion and extubation, and then every 2 hours 
after. If pain was reported of higher than mild severity, morphine 2 mg was administered, 
with additional doses until patient reported a verbal pain score less than 3. Oral pain 
management was transitioned once the patient was discharged from the ICU to the 
surgical ward, which consisted of one hydrocodone-acetaminophen 10/325 mg tab for 
mild pain, and two tabs for moderate pain. Once on the surgical ward, patients’ pain 
scores were evaluated every four to six hours and morphine or oral pain management was 
administered as needed.  
In the initial 15 minutes in recovery, patients in the methadone group reported a 
median pain score of 3, versus the fentanyl group at 5 (p value <0.001). At two hours, the 
methadone group reported a median of 3 at rest and 4 with coughing, and the fentanyl 
group reported median of 4.5 and 7, respectively (p < 0.001). At 12 hours, the methadone 
group reported pain score median of 2, 4 with coughing, and in the fentanyl group, 4 and 
6 respectively. Median pain scores at 24, 48 and 72 hours at rest in the methadone group 
was 2 for each time, and with coughing: 5 at 24 hours and 4 at 48 and 72 hours. As 
comparison, in the fentanyl group, the median scores at rest were 4 at 24 hours and 3, at 
48 and 72 hours, and with coughing 7 at 24 hours, 6 at 48 hours and 5 at 72 hours. 
Overall satisfaction of pain management was also collected at these times using the VAS 
and ranged from 90-100 in the methadone group, and in the fentanyl group ranged from 
70-90.  
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Opioid related complications were reported as nausea, vomiting, itching, 
hypoventilation, hypoxemia and sedation. In the methadone group, nausea was reported 
in 50%, vomiting 24%, itching 22%, hypoventilation 4%, hypoxemia 13% and sedation 
83%. In the fentanyl group, nausea was reported in 56%, vomiting 19%, itching 12%, 
hypoventilation 4%, hypoxemia 8% and sedation 90%.  
Murphy et al. (2015) reported decreased morphine requirements in the first 24 
hours after cardiac surgery and improved pain scores 12 hours after extubation, 
summarized in median and interquartile ranges. These variables were compared between 
both randomized groups utilizing the Mann-Whitney U test and median differences and 
their 99% Cis were calculated. Murphy et al. (2015), concluded that intravenous 
morphine requirements during the first 24 hours after surgery and total doses of 
postoperative morphine were reduced by 40% in the methadone group. They reported 
that nearly one third of the patients in the fentanyl group required high dose morphine, 
defined by greater than 20 mg, for pain control in the first 24 hours. This was compared 
to the 2.5% of patients in the methadone group that required high dose morphine in the 
postoperative period. Additionally, the five patients that did not require morphine 24 
hours postoperatively were all from the methadone group. 
A few limitations were noted within the study conducted by Murphy et al. (2015). 
Although a safe and effective dose of methadone was used intraoperatively for the 
purpose of this study, the most optimal methadone dose was not determined. 
Additionally, the pain scale was only reported until 72 hours postoperative, and high risk 
cardiac patients were excluded from enrollment of the study.  
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The study conducted by Murphy et al. (2015) reported participant inclusion and 
exclusion criteria, and the number of patients assessed for the study. A CONSORT chart 
(Appendix H-3) was created to evaluate the sample selection, allocation and attrition of 
the study. Eight patients were excluded before completion of the ICU data collection due 
to protocol violations, study drug unavailable at start of surgery, canceled surgery due to 
calcified aorta, and patient death after ICU arrival. A large sample size of 156 
participants completed the study and were included in the final analysis.  
Thoracic Surgery  
Matot, Drenger, Weissman, Shauli and Gozal (2004) conducted a study using 
clonidine, bupivacaine and methadone as sole analgesics for patients undergoing a 
thoracotomy for lung resection. The study evaluated 47 patients undergoing a lung 
resection and treated postoperatively for 72 hours with one of the study drugs. One of the 
main objectives of this study was to evaluate lung function and evaluated spirometry 
throughout the study, along with pain management. For purposes of this systematic 
review, pain scores will be the only reported values.  
Patients were premedicated with diazepam 10 mg orally, one hour prior to the 
procedure. In the operating room, an epidural catheter was placed at either T4-T5 or T5-
T6 intervertebral space with 4 cm of catheter in the epidural space. A 3 mL test dose of 
lidocaine 2% with epinephrine (1:200,000) was administered, followed by 10 mL of 
bupivacaine 0.25%. Correct placement of the catheter was confirmed by a sensory loss of 
cold sensation above T4. A minimum of 20 minutes elapsed before start of surgery to 
allow for achievement of effect. General anesthesia was then induced with Propofol 2 
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mg/kg, fentanyl 2 mcg/kg and vecuronium 0.1 mg/kg. Maintenance of anesthesia was 
achieved with isoflurane in a 50% oxygen-nitrous oxide mixture. Additional doses of 
fentanyl 1.5 mcg/kg were administered when mean arterial pressure or heart rate 
increased 25% from the baseline value. Additional boluses of vecuronium were 
administered when clinically required.  
During skin closure, patients were selected and placed into a double blinded 
group to receive one of the three study drugs for postoperative analgesia. Patients in the 
clonidine group received an initial dose of clonidine 8 mcg/kg in 10 mL of saline over 20 
minutes, followed by an infusion of 1 mcg/kg/hr. Patients in the bupivacaine group 
received an initial dose of 10 mL of 0.25% bupivacaine over 20 minutes, followed by an 
infusion of 0.125% bupivacaine. Patients in the methadone group received an initial dose 
of 6 mg of methadone in 10 mL of normal saline over 20 minutes, followed by an 
infusion of 0.5 mg/hr. The maintenance infusion of each group ran during the first 72 
hours postoperatively and pain scores were recorded at 8, 24, 48 and 72 hours. On a 
numerical pain scale from 0-10, if pain scores were greater than or equal to a 3 at rest, or 
4 with coughing, patients were given diclofenac 75 mg, a nonsteroidal anti-inflammatory 
drug (NSAID), intramuscularly.  
Matot et al. (2004) reported pain scores determined by the NRS were not 
statistically significant throughout the study period. The study reported in all groups, pain 
was significantly lower at 72 hours compared to those at 8 and 24 hours. By the third day, 
the bupivacaine group required more diclofenac than the clonidine or methadone groups 
to achieve pain scores lower than 3 at rest or 4 with coughing. The bupivacaine group 
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required 575 mg (standard deviation 115), clonidine 325 mg (SD 90) and methadone 
group 300 mg (SD 120). The study recorded adverse side effects, including pruritis, 
vomiting, hypotension, bradycardia, weakness or numbness of limbs, urinary retention 
and sedation. Methadone was the only group in which 3 patients, or 21%, reported 
pruritis. Each group reported vomiting, 6% in the clonidine group, 12% in the 
bupivacaine group and 28% in the methadone group. Hypotension and bradycardia were 
not noted in the methadone group. Hypotension occurred in both 24% of the clonidine 
and bupivacaine groups, and bradycardia only occurred in 12% of the clonidine group. 
Weakness or numbness of limbs was reported in 12% of the bupivacaine group and in 
neither of the methadone or clonidine group. All groups reported urinary retention. 
Sedation was reported in 18% of the clonidine group, 0% of the bupivacaine group, and 
14% of the methadone group.  
The study conducted by Matot et al. (2004) demonstrated pain scores on the NRS 
were not statistically significant between the groups throughout the study period. By the 
third postoperative day, it was reported the bupivacaine group required slightly more 
diclofenac to achieve pain scores less than or equal to 3 at rest, or 4 with coughing. A few 
limitations existed within the study. One limitation of the dose of clonidine was selected 
based on previous reports of clonidine usage in controlling postoperative pain. The dose 
selected for this study was based on previous studies concluding that higher doses caused 
excessive patient sedation and hemodynamic instability, which were two variables 
studied and reported. The study also lacked a placebo group, and reported on small, 
unequal populations within each group.  
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A CONSORT flow diagram was created for this study to collect data reported 
regarding sample selection, allocation and attrition rates (Appendix H-4). The study did 
not provide information regarding the 7 patients that were excluded due to intraoperative 
reasons. There were no participants lost to analysis or follow up after the initial selection 
and randomization of treatment groups. 
 Perez et al. (2007) evaluated epidural methadone for acute post thoracotomy pain 
versus ropivacaine with fentanyl. The study was a prospective, randomized, open labeled 
clinical trial that compared two epidural analgesic regimens. Patients scheduled for an 
elective thoracotomy for lung resection surgery, age range 54-61, ASA II-III. A total of 
49 patients over a 4-month period were included in this study.  
Preoperative anesthetic management included midazolam (dosage not specified). 
Before induction of general anesthesia, an epidural catheter was placed at T8-9 
intervertebral space and a test dose of 4 mL of 2% lidocaine with adrenaline was 
administered. General anesthesia was induced with propofol, fentanyl, and rocuronium. 
Maintenance of anesthesia included propofol, remifentanil and rocuronium. Dosages for 
drugs during both phases were not reported. Postoperative analgesia was initiated on 
chest closure with 5 mL of ropivacaine 0.5%. Patients were randomized to two groups, 
patient controlled epidural analgesia (PCEA) and epidural methadone. The PCEA group 
received a continuous infusion of 0.16% ropivacaine plus fentanyl 3.5 mcg at a 
continuous rate of 6-10 mL/hr, along with a patient controlled, self-administration dose of 
4 mL boluses with a lockout interval of 20 minutes between each bolus. The epidural 
methadone group received boluses every 8 hours of 4-6 mg preservative free 0.1% 
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methadone, based on a formula including patients weight and age. Both groups received 
intravenous ketorolac 30 mg every 8 hours, and rescue analgesia included propacetamol 
four times daily when pain at rest was reported equal to, or above a 3 on the NRS. 
Epidural analgesia was administered to the PCEA group over 3.3 ± 0.1 days and 3.7 ± 0.2 
days in the methadone group.  
Pain scores were taken at 1, 2, 6, 12, 24 and 48 hours after the procedure. Initially, 
69.6% of the methadone group requested rescue analgesic at 1 hour versus 44% in the 
PCEA ropivacaine with fentanyl group. However, patients in the PCEA group requested 
more rescue analgesia during the first 24 and 48 hours compared to the methadone group. 
At 24 hours, 32% of the PCEA group requested rescue analgesia versus 8.7% in the 
methadone group, and at 48 hours, 28% versus 0% respectively, requested rescue 
analgesia. Secondary effects, sedation, hypotension, motor blockade, vomiting and 
pruritis were recorded for each group. Sedation, hypotension, vomiting and pruritis were 
reported at 1 hour and two reports were given for 24 hours, some with different values. In 
the methods section, the authors report secondary adverse effects were recorded during 
the first 48 hours.  It is unclear if the author made a mistake and mislabeled the time 
reported in the secondary effects table. No other secondary effects at 48 hours are 
reported within the article. The following information is reported as it has been reported 
in the study. Sedation scores in the PCEA group were 28% at 1 hour, 0% at 24 hours and 
4% at 24 hours in the PCEA group, and 39.1%, 13% and 15% in the methadone group, 
respectively. Hypotension ranged from 0-28% through the 1-24 hours in the PCEA 
group, and 0-8.7% in the methadone group. Neither group reported a prolonged motor 
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blockade during any interval postoperatively. Vomiting in the PCEA group ranged from 
0-12% in 1 hour to 24 hours postoperatively versus methadone which sustained 13% 
through all periods. Less than 5% of pruritis was reported in the PCEA group and 4.3% 
was reported in the methadone at 24 hours, but was not reported during other intervals. A 
telephone survey was carried out four months after the procedure to evaluate for chronic 
pain. Two patients from the PCEA group reported persistent thoracic pain and 1 from the 
methadone group. Researchers concluded a total incidence of 6.1% prevalence of chronic 
postoperative chronic pain was found.  
The CONSORT flow diagram was used to report sample selection, allocation and 
attrition (Appendix H-5). There were no reports of patients excluded from the study or 
loss of participants during the study. Limitations included small sample size and 
ambiguous data regarding interval of recording. Although drugs were administered via 
the same epidural route, they were on different time intervals and patients in the PCEA 
group received a continuous infusion and had the option to self-administer a dose when 
they felt necessary, versus the methadone group that received bolus dosage every eight 
hours.  
Cross Study Analysis 
 The randomized control trials used for this systematic review were analyzed 
across studies utilizing data extracted and organized in the data collection sheet 
previously shown in Table 2. This tool was used to record and analyze surgery time, time 
to extubation, time to first rescue analgesic, NRS score in the first 24 hours, NRS over 
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the length of time the study evaluated pain, reported rescue drug use and adverse events 
(Appendix I). 
 Mixed results regarding the efficacy and improvement in pain scores and adverse 
reactions to methadone treatment throughout the perioperative period were presented 
through cross study analysis of the studies involved in this systematic review. The study 
conducted by Murphy et al. (2015) (Appendix I) significant reduction in postoperative 
NRS scores and opioid use was noted within the methadone group compared to the 
fentanyl group.  Initial time to first rescue analgesic dose in the methadone group ranged 
from 3.25-9.25 hours, versus the fentanyl group requiring analgesia much sooner, at 1.5-
5.75 hours. Pain scores at rest were significantly less in the methadone group than the 
fentanyl group throughout the first 72 hours (P <0.001 to 0.002). Similarly, pain scores 
while coughing were less in the methadone group than in the fentanyl group throughout 
the first 3 postoperative days (all P < 0.001). Intravenous morphine requirements in the 
methadone group were reduced by 40% during the first 24 hours postoperatively and 
reported a higher patient perceived quality of pain management. Perez et al. (2007) 
(Appendix I) found epidural methadone had a reduction in rescue analgesia in the 
methadone group versus PCEA ropivacaine with fentanyl group. Although the study 
found that rescue analgesia at 1 hour was increased in the methadone group, it was 
significantly decreased at 24 and 48 hours. The percentage of patients that requested 
doses of rescue analgesia was reported as 8.7% and 0% at 24 and 48 hours in the 
methadone group, and in the PCEA group 32% and 28%, respectively (P < 0.05). Matot 
et al. (2004) reported a significant difference (P < 0.05) in pain scores among participants 
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that received clonidine, bupivacaine and methadone for postoperative thoracotomy pain. 
The study reported little significance between the three drugs but did note the participants 
in the bupivacaine needed significantly more rescue analgesia to achieve lower scores 
when compared to the clonidine and methadone groups.   
 Lastly, in the two studies by Carvalho et al. (2011) and Udelsmann et al. (2011) 
both compared methadone to morphine and found methadone superior in the 
management of postoperative pain relief. Carvalho reported a methadone efficacy 22% 
higher than that of morphine, with pain scores lower at 12 and 24 hours postoperative, 
(p= 0.186) and (p= 0.029). Udelsmann reported the first dose of analgesic in the 
methadone group was requested after a longer period of time (p = 0.0261). In addition, 
the number of patients that required analgesics was significantly lower in the methadone 
group (p = 0.025) and the quality of analgesia was improved in the methadone group (p < 
0.01).  
 Adverse events reported among all of the studies included nausea, vomiting, 
respiratory failure, sedation, hypotension, bradycardia, pruritis, hypoventilation, and 
hypoxemia. Nausea and/or vomiting or described as postoperative nausea and vomiting 
(PONV), were among the most common side effects throughout all studies in both the 
methadone and intervention groups. Data regarding these side effects were similar across 
all studies comparing methadone to other opioids such as morphine and fentanyl. 
Udelsmann (2011) did show the incidence of PONV was significantly lower than in the 
methadone group versus the other two groups (p= 0.013).  
 Next, summary and conclusions section will be presented. 
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Summary and Conclusions 
 Pain plays a significant role of the perioperative period and is much anticipated 
after surgery. Patients often express postoperative pain as a major concern, with 
uncontrolled pain being a primary fear (Hutchinson, 2007).  As a result, postoperative 
pain control is a primary goal for patients and providers. Persistent acute pain is 
associated with increased risk of morbidity, impairment of functionality and quality of 
life, delays in recovery, increased financial burden and prolonged opioid usage (Gan, 
2017). Health risks such as impaired mobilization, deep vein thrombosis, pneumonia, 
respiratory failure, pulmonary embolism and wound infections can further spiral into 
negative consequences that can relate to increased morbidity and mortality (Hutchinson, 
2007). Furthermore, prolonged acute pain can lead to the development of chronic pain, 
which can contribute to disability, depression, reduced quality of life, morbidity and 
mortality (Gan, 2017). Management of pain throughout the perioperative period is crucial 
to successful management of the surgical patient. The purpose of this paper is to conduct 
a systematic review to determine if intraoperative methadone administration will affect 
postoperative pain after cardiothoracic and thoracic surgery as evidenced by pain score 
levels and documented postoperative opioid use. 
 A literature review was conducted utilizing a table with inclusion and exclusion 
criteria created by the author. The PRISMA checklist (Appendix A) was used to review 
each article prior to selection. The PRISMA flow diagram was then used to assist in the 
organization and collection of data from the literature search (Appendix F). A total of 
five randomized control trials were selected. The randomized control trials were further 
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critiqued using the CONSORT checklist (Appendix B) to evaluate strength and 
significance of the studies discussed in this systematic review. Data was collected from 
each of the articles and information was recorded within tables created by the author 
(Appendix C). Information drawn from each study included author, publication year, 
number of patients in the trial, age of participants, gender, ASA score, procedure, 
duration, methadone group, control group and route of drug administration, agents used 
for induction of anesthesia, agents for maintenance of anesthesia, administration time of 
study drug, intraoperative dose of methadone, intraoperative control dose, recue pain 
dosing, time to first rescue analgesic for methadone group, time to first rescue analgesic 
for control group (Appendix G-1, 2).  Strengths and weaknesses from each study were 
recorded in a separate table created by the author of this review using the criteria 
published from the CONSORT checklist (Appendix G-3).  With the focus on sample size, 
randomization and attrition rates of participants for each randomized control trial, a 
PRISMA flow diagram was completed for each study (Appendix H-1, 2, 3, 4, 5). 
Analysis across the studies was completed utilizing the chart in Appendix I. This chart 
recorded the surgical time, time to extubation, time to first rescue analgesic, the 
numerical rating scale (NRS) score in the first day, the NRS score in extended periods, 
reported rescue drug use and adverse events. 
 Three of the studies reported the amount of time that passed until the patient 
required their first rescue analgesic in each of the groups. Carvalho et al., (2011) reported 
that the rescue dose of analgesia was required sooner in the methadone group than in the 
morphine group.  (Appendix G-2). Udelsman et al., (2011) and Murphy et al., (2015), 
54 
 
 
reported time to first rescue analgesic was much more delayed in the methadone group in 
each of their studies versus the control group (Appendix G-2). With the exception of 
Matot (2004), which reported no clinical significance between the three drugs studied, the 
other four studies showed that the patients in the methadone group reported overall lower 
pain scores on the NRS scale in the first 24 hours (Appendix I). Reports of pain scores 
later than 24 hours postoperative were not reported in two of the studies. In the trial 
conducted by Carvalho et al., (2011), pain scores were similar in both groups at 36 hours 
postoperatively. Murphy et al., (2017), reported slight improvement in pain scores in the 
methadone group at 72 hours postoperative (Appendix I). Perez et al., (2007), reported no 
additional pain management requirements at 48 hours postoperative in the methadone and 
28% of patients requesting additional pain management in the ropivacaine plus fentanyl 
group (Appendix I).  
 Adverse effects noted from the drugs were recorded in all five of the studies 
presented. The most commonly presented side effect of the drugs were postoperative 
nausea and vomiting (PONV). Of the studies that compared other opioids, such as 
morphine to methadone, the data regarding PONV was similar. Nausea with vomiting 
ranged from 5-28% of patients and was not highly significant based on the opioid the 
patient was given. Other side effects reported included pruritis, respiratory failure, 
hypoxemia, hypoventilation, sedation, hypotension, bradycardia, urinary retention, and 
limb weakness (Appendix I).  
 Limitations existed in this systematic review. Although studies included in this 
review fulfilled the inclusion criteria, the inclusion of five randomized control trials with 
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relatively small sample sizes may decrease the generalizability of this study. 
Additionally, the review may have been more generalizable if all participants had the 
same surgical procedure, same control drug and if the drug was given by the same route 
in each study. The rescue drug in two of the trials by Carvalho et al. (2011) and 
Udelsmann et al. (2011) used morphine as the control drug and also as the rescue 
analgesic. This may have affected the strength of the results.  
 Diversity varied greatly among the five randomized control trials and may have 
contributed to a weakened conclusion of the study. Each study administered the 
methadone and control drug at different time intervals during the operation and by 
different routes. Some studies administered the drug after induction of anesthesia, while 
Murphy et al. (2015) administered half after induction and then the other half over the 
following two hours. Carvalho et al. (2011) administered the drug at the end of the 
surgery, but did not specify when, while Matot et al. (2004) administered the drug during 
skin closure and Perez et al. (2007) administered at the closure of the chest cavity. Four 
of the five studies administered the drug intravenously, and one administered the drug via 
epidural route. Although each study reported the overall NRS scores in the first 24 hours 
after drug administration, some studies failed to record NRS scores further than 24 hours. 
This potentially could have weakened the conclusions of the study, as methadone half-
life can range greatly among individuals and exert a prolonged effect up to 90 hours 
(Barbosa Neto, et al., 2014). Additionally, the studies reported by Matot et al. (2004) and 
Perez et al. (2007) did not document the time of the first requested rescue analgesic after 
the methadone or control drug was administered (Appendix G-2).  
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 Due to the many limitations, this systematic review does not provide sufficient 
evidence to implicate the use of methadone as an effective means to decrease 
postoperative pain after thoracic surgery. Recommendations and implications for 
advanced nursing practice will be discussed in the next section.  
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Recommendations and Implications for Advanced Nursing Practice 
 Advanced Practice Registered Nurses (APRNs), including Certified Registered 
Nurse Anesthetists (CRNAs) rely on evidence-based research to care for patients. 
Systematic reviews are frequently reviewed to evaluate a large sum of information 
throughout multiple published studies to present recommendations for best practice. This 
supports safe practice and the most up to date knowledge informing the anesthesia 
community. CRNAs provide anesthesia to patients undergoing cardiothoracic or thoracic 
surgery until the procedure is completed and the patient is transported to their respective 
recovery areas and care is designated to the registered nurse in the Post Anesthesia 
Recovery Unit (PACU) or Intensive Care Unit (ICU). Treatment of pain throughout a 
procedure or surgery is important not only during the procedure, but for the prevention of 
pain upon their arrival and stay in the PACU or ICU.  
 The delivery of anesthesia is often defined as the combination of both science and 
art. Ability to provide anesthesia is achieved through extensive training in both classroom 
and surgical settings with a focus on the delivery of safe, effective and appropriate 
anesthesia. Continued education and reviewing current research is crucial for the 
anesthesia provider and the safety of their patients. Systematic reviews, such as this one, 
are intended to review multiple research articles and extract information that may be 
useful to better serve the surgical population undergoing anesthesia. It allows for CRNAs 
to consider the most up to date, safest and most effective methods of providing 
anesthesia.  
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 One of the most important factors in providing an effective anesthesia involves 
the treatment of pain. Prevention and treatment of pain is often discussed and disputed 
due to the multiple options for pain management. Methadone is often stigmatized due to 
its use in opioid addiction treatment programs. It is also often used in the treatment of 
chronic pain, especially in patients with cancer. The use of methadone within the 
operating room for standard procedures is not widely discussed nor used. The purpose of 
this paper is to conduct a systematic review to determine if intraoperative methadone 
administration will affect postoperative pain after cardiothoracic and thoracic surgery as 
evidenced by pain score levels and documented postoperative opioid use. 
 The use of methadone during the perioperative phase of cardiothoracic and 
thoracic surgery in this systematic review had mixed results. As noted on Appendix I, the 
NRS scores were not significantly different across all of the studies in the methadone 
group. However, utilizing methadone in the surgeries specific to cardiothoracic, slight 
improvements in pain scores were noted. This may present a need for future randomized 
control trials to evaluate the use of methadone pertaining specifically to cardiothoracic 
surgery. Future studies may be performed comparing methadone and morphine, with the 
recommendation of a rescue drug being different than the one utilized as a control drug, 
as most of these studies used morphine in the intraoperative and postoperative pain 
management. These studies would be essential to evaluate the most effective 
management of pain in the population of thoracic surgical patients.  
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Appendix C 
Data Collection Chart #1  
 
 
 
 
 Author, Year #Pt  Ages (yr) M/F ASA Procedure Duration 
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Appendix D 
Data Collection Chart #2 
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Appendix E 
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Type 
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Appendix G-1 
Data Collection Chart #1  
 
NR= Not Reported 
 
ASA Physical Status Classification System 
ASA I: A normal, healthy patient  
ASA II: A patient with mild systemic disease 
ASA III: A patient with severe systemic disease  
ASA IV: A patient with severe systemic disease that is a constant threat to life 
ASA V: A moribund patient who is not expected to survive without the operation  
ASA VI: A declared brain-dead patient whose organs are being removed for donor purposes  
 
 Author, 
Year 
#Pt  Ages 
(yr) 
M/F ASA Procedure Duration 
(min) 
Methadone 
Group 
Control Group Route 
a Carvalho, 
2011 
100 52-73 63/37 III/IV CABG 140-253 n = 50 Morphine n = 50 IV 
b Udelsman
n, 
2011 
55 40-72 30/25 III-IV Cardiac 
Surgery 
228-373 n = 18 Morphine n = 19 
saline n = 18 
NR 
(inferred IV)  
c Murphy, 
2015 
156 54-76 115/4
1 
III-IV CABG, Valve, 
CABG and 
Valve, ASD 
324-371 n = 77 Fentanyl n = 79 IV 
d Matot, 
2004 
47 43-72 29/18 I-III Lung Resection 92-278 n = 14 Clonidine n = 16 
bupivacaine n = 17 
Epidural 
e Perez, 
2007 
49 54-61 NR II-III Lung Resection 138-210 n = 24 ropivacaine plus 
fentanyl  n = 25 
Bolus/ PCEA 
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Appendix G-2 
Data Collection Chart #2 
 Author, Year Agents for 
Induction of 
Anesthesia 
Agents for 
Maintenance of 
Anesthesia   
Admin 
time of 
study 
drug  
Intraop 
methadone 
dose 
Intraoperative 
Control Dose 
Rescue pain 
dosing in 
recovery 
Time to 1st 
rescue 
analgesic 
(hours) 
methadone 
Time to 1st 
rescue 
analgesic 
(hours) 
Control group 
a Carvalho, 
2011 
sufentanil 
0.5 mcg/kg, 
10 mcg 
bolus PRN,  
etomidate 
0.2mg/kg, 
rocuronium 
01.mg/kg 
sufentanil 0.25-
0.5 mcg/kg/hr, 
sevoflurane 0.5-1 
MAC 
End of 
surgery 
methadone 
0.1 mg/kg  
morphine 0.1 
mg/kg  
Dipyrone 1 g 
q 6 hours 
continuous, 
 
morphine 
0.03 mg/kg 
Limit: 0.1 
mg/kg in 4h 
2.43 ± 2.98 4.49 ± 4.22 
b Udelsmann, 
2011 
sufentanil 
0.1mcg/kg, 
midazolam, 
pancuroniu
m 0.1mg/kg 
Sufentanil 0.01 
mcg/min, 
isoflurane 0.5% 
and pancuronium 
0.03mg/kg prn 
After 
inducti
on 
methadone 
20 mg  
morphine 20 
mg  
Or  
saline 2 mL 
morphine 
0.03 mg/kg 
prn 
14.25 ± 
9.89 hours  
morphine: 
10.43 ± 8.75 
saline: 8.46 ± 
6.88 
c Murphy, 
2015 
midazolam 
4-6 mg PO, 
propofol 20-
100mg*, 
rocuronium 
sevoflurane 0.4-
3%** 
rocuronium,  
midazolam 5mg 
during 
½ at 
inducti
on 
½ 
infused 
methadone 
0.15 mg/kg  
fentanyl 6 
mcg/kg 
morphine 2 
mg until pain 
< 3  
hydrocodone
/ APAP 1 tab 
6.5 (3.25-
9.25) 
3.75 (1.5-
5.75)  
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0.6-
08.mg/kg 
rewarming, 
propofol 10-
50mcg/kg/min @ 
closure  
over 
next 2 
hrs 
mild pain, 2 
tabs for 
moderate-
severe pain 
d Matot, 2004 diazepam 10 
mg PO,  
propofol 2 
mg/kg, 
fentanyl 2 
mcg/kg, 
vecuronium 
0.1 mg/kg 
isoflurane and a 
50% oxygen with 
nitrous oxide 
mixture with 
fentanyl 1.5 
mcg/kg boluses 
prn pain 
Skin 
closure 
at end 
of case  
methadone 
6 mg 
bolus, 
infusion of 
0.5 mg/hr 
clonidine: 8 
mcg/kg 
bolus with 
infusion 1 
mcg/kg/hr 
 
bupivacaine: 
0.25% 10 
mL bolus, 
then 0.125% 
infusion of          
10 ml/hr  
diclofenac 
75 mg IM 
NR  NR  
e Perez, 2007 midazolam, 
propofol, 
fentanyl, 
rocuronium 
(doses NR) 
propofol, fentanyl 
and rocuronium 
(doses NR) 
Closure 
of chest 
cavity 
methadone 
4-6 mg 
epidural 
0.1% q 8 
hour bolus  
ropivacaine 
0.16%  plus 
fentanyl 3.5 
mcg CI 6-
10ml/hr. 
 
Scheduled 
ketorolac 30 
mg q 8 hr. 
Rescue: 
propacetamo
l  2mg QID 
NR NR 
 
ABW: Adjusted Body Weight  
*- titrated to loss of consciousness  
**- titrated to BIS monitoring of 40-60 and MAPs within 20% of baseline 
 
CI= Continuous Infusion  
NR= Not Reported 
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Appendix G-3 
Randomized Control Trial Appraisal Chart  
 
 Author, 
Year 
Study 
Type 
Consent/ 
Funding 
Inclusion 
Criteria 
Exclusion 
Criteria 
Randomization Attrition Blinding  Strengths Limitations 
a Carvalho,  
2011 
RCT, 
double 
blind, 
parallel 
clinical 
trial  
Ethics 
Committee 
approval, 
Written 
informed 
consent  
M/F, over 
18 years, 
ASA III or 
IV, CABG 
without 
Cardiopul
monary 
bypass 
(CPB) 
Illicit drug 
use, 
allergies to 
medications 
used, those 
remained 
intubated 
>12 hours 
postop 
Block 
randomized 
into two 
treatment 
groups and 
passed to head 
of department 
to determine 
treatment 
group   
n = 4: 
1 death, one 
reintubation 
and 2 
intubated > 
12 hours  
Patients, 
researcher
s and 
research 
assistants 
blinded 
Generaliz-
able, no 
proportional 
difference 
between 
gender 
groups, 
methadone 
efficacy 22% 
higher 
Only looked 
at first 36 
postop hours, 
pain is 
extremely 
subjective, no 
standardized 
measure for 
assessing 
level of 
sedation 
b Udelsmann,  
2011 
RCT, 
double 
blind 
study  
Ethics 
Committee 
approval, 
informed 
consent  
Male, 
female, 14-
80 years 
old, ASA 
III or IV, 
cardiac 
surgery 
with CPB 
Illicit drugs 
or 
antidepressa
nts, 
psychiatric 
disease, 
allergies to 
drugs used, 
intubation 
>24 hours 
postoperativ
ely  
NR NR Anesthesi
a MD and 
patient  
Generaliz-
able, no 
proportional 
difference 
between 
gender 
groups, 
Evaluated 
number of 
patients 
requiring 
analgesics 
and NRS 
scores 
Small sample 
size, Poor 
description of 
methods, 
randomizatio
n and 
attrition, pain 
scores 
recorded at 
24 hours 
postoperative, 
no report on 
levels of pain 
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 Author, 
Year 
Study 
Type 
Consent/ 
Funding 
Inclusion 
Criteria 
Exclusion 
Criteria 
Randomization Attrition Blinding  Strengths Limitations 
throughout 24 
hours- 
published as a 
mean of pain 
score 
throughout 24 
hour period  
c Murphy, 
2015 
RCT, 
double 
blind 
IRB 
approval, 
written 
informed 
consent  
Elective 
cardiac 
surgery 
(CABG, 
valve, 
CABG and 
valve, and  
atrial 
septal 
defect 
repair) 
with CPB 
and 
extubation 
<12 hours 
from 
surgery 
Preop renal 
failure 
requiring 
dialysis, 
serum 
creatinine 
>2.0, 
significant 
hepatic 
dysfunction, 
EF <30%, 
home O2 
therapy, 
emergency 
surgery, 
preoperative 
requirement 
of 
inotropes/I
ABP, 
allergy to 
drugs in 
Computer 
generated 
randomization 
code 
n= 8: 
3 protocol 
violations, 1 
canceled 
surgery, 1 
study drug 
unavailable 
at time of 
surgery, 2 
severe HTN 
prior to start 
of study 
drug, 1 
death  
All 
research 
team 
members 
and 
nurses  
Large 
sample size, 
double 
blinded 
 
Highly 
significant 
findings: 
 p <0.001 
Mann-
Whitney U 
test 
Optimal 
intraoperative 
dose of 
methadone 
not 
determined, 
only followed 
for 72 hours, 
high risk 
cardiac 
patients were  
excluded, 
chronic pain 
not reported 
postop  
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 Author, 
Year 
Study 
Type 
Consent/ 
Funding 
Inclusion 
Criteria 
Exclusion 
Criteria 
Randomization Attrition Blinding  Strengths Limitations 
study, 
opioid 
abuse or 
preoperative 
opioid use  
d Matot, 2004 RCT, 
double 
blind  
prospec
tive 
study  
IRB 
approval, 
Written 
and 
informed 
consent 
>18 years 
old, 
elective 
thoracotom
y for left 
lobectomy  
Contraindic
ation to 
epidural, 
chronic 
NSAID use, 
allergy to 
drugs, lack 
of co-
operation, 
renal or 
hepatic 
dysfunction, 
use of 
clonidine, 
chronic 
opioids or 
psychotropi
c drugs, 
history of 
chronic 
pain, resting 
HR <50 or 
left bundle 
branch 
During skin 
closure, 
randomly 
allocated to a 
table of 
random 
numbers for 1 
of 3 
postoperative 
epidural 
analgesia  
n = 7 
excluded 
for 
intraoperati
ve reasons  
Double 
blinded  
Evaluated 3 
different 
classes of 
drugs: 
opioid, local 
anesthetic 
and alpha 
agonist  
Option for 
best analgesic 
based 
primarily on 
PFTs, small 
sample size, 
limited 
information 
regarding 
pain 
management, 
evaluated 
pain for 72 
hours, pain 
scores not 
reported, not 
described 
how the study 
was blinded, 
unequal 
intervention 
groups  
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 Author, 
Year 
Study 
Type 
Consent/ 
Funding 
Inclusion 
Criteria 
Exclusion 
Criteria 
Randomization Attrition Blinding  Strengths Limitations 
block or 
need for 
more 
extensive 
surgery 
 
 
 
 
e Perez, 2007 Prospec
tive, 
RCT, 
open 
label 
clinical 
trial  
Ethics 
committee 
approval 
Informed, 
signed 
consent  
ASA II or 
III, 
scheduled 
elective 
thoracotom
y for lung 
resection 
surgery, 
No 
contraindic
ations to 
epidural, 
preoperativ
e FEV1 
>1000mL 
Contraindic
ations to 
epidural 
including: 
coagulation 
impairment 
or patient 
refusal, 
preoperative 
FEV1 
<1000mL 
Computer 
generated 
program into  2 
groups  
0 Non-
blinded 
open 
study 
High degree 
of treatment 
satisfaction, 
48 hour 
study with a 
4 month 
telephone 
follow up, 
patient 
demographic
s 
proportional 
Non-blinded, 
small sample 
size, time to 
first analgesic 
dose not well 
described  
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Appendix H-2 
Patients undergoing Cardiac 
Bypass Surgery  
(n = 145) 
En
rol
lm
en
t 
Eligible patients  
(n =  112) 
Randomized (n = 104) 
Allocated to morphine 
Group 
Received allocated 
intervention (n= 52) 
Lost to follow up 
(n = 2) 
1 death, 1 intubation 
>12 hours 
Discontinued 
intervention 
(n= 0) 
 
Analyzed (n= 50) 
Excluded from analysis: 
see above 
Patients ineligible due 
to non-myocardial 
revascularization  
(n = 32) 
Excluded for 
requiring 
cardiopulmonary 
bypass 
(n =8) 
Allocated to methadone 
Group 
Received allocated 
intervention (n= 52) 
Lost to follow up 
(n = 2) 
1 reintubation, 1 
intubation >12 hours 
Discontinued 
intervention 
(n= 0) 
 
Analyzed (n= 50) 
Excluded from analysis: 
see above 
 
Al
loc
ati
on
 
Fo
llo
w 
Up
 
An
aly
sis
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Appendix H-3 
Patients enrolled  
(n = 55) 
En
rol
lm
en
t 
Eligible patients  
(n= 55) 
Randomized (n = 55) 
Allocated to 
methadone Group 
Received allocated 
intervention (n= 18) 
Lost to follow up 
(n = 0) 
Discontinued 
intervention 
(n= 0) 
 
Analyzed (n= 18) 
Excluded from 
analysis 
(n= 0) 
Allocated to control 
Group 
Received allocated 
intervention (n= 18) 
Analyzed (n= 18) 
Excluded from 
analysis 
(n=0) 
 
Al
loc
ati
on
 
Fo
llo
w 
Up
 
An
aly
sis
 
Lost to follow up 
(n = 0) 
Discontinued 
intervention 
(n= 0) 
 
Allocated to 
morphine Group 
Received allocated 
intervention (n= 19) 
Lost to follow up 
(n = 0) 
Discontinued 
intervention 
(n= 0) 
 
Analyzed (n= 19) 
Excluded from 
analysis 
(n= 0) 
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Appendix H-4 
Matot, I., Drenger, B., Weissman, C., Shauli, A., & Gozal, Y. (2004). Epidural clonidine,  
Patients enrolled  
(n = 164) 
En
rol
lm
en
t 
Eligible patients  
(n= 156) 
Randomized (n = 156) 
Allocated to methadone 
Group 
Received allocated 
intervention (n= 77) 
Lost to follow up 
(n = 0) 
Discontinued intervention 
(n= 0) 
 
Analyzed (n= 77) 
Excluded from analysis  
(n= 0) 
Patients ineligible due to: 
Protocol violation (n=3) 
Surgery canceled (n= 1) 
Study drug unavailable 
(n= 2) 
Severe hypertension prior 
to start (n= 1) 
Patient death (n= 1) 
Total (n= 8) 
 
Allocated to fentanyl 
Group 
Received allocated 
intervention (n= 79) 
Analyzed (n= 79) 
Excluded from analysis 
(n=0) 
 
Al
loc
ati
on
 
Fo
llo
w 
Up
 
An
aly
sis
 
Lost to follow up 
(n = 0) 
Discontinued intervention 
(n= 0) 
 
81 
 
 
bupivacaine and methadone as the sole analgesic agent after thoracotomy for lung 
resection. Anaesthesia, 59, 861-866.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients enrolled  
(n = 54) 
En
rol
lm
en
t 
Eligible patients  
(n= 47) 
Randomized (n = 47) 
Allocated to 
clonidine Group 
Received allocated 
intervention (n= 16) 
Lost to follow up 
(n = 0) 
Discontinued 
intervention 
(n= 0) 
 
Analyzed (n= 16) 
Excluded from 
analysis  
(n= 0) 
Excluded for intraoperative 
reasons  
Total (n= 7) 
 
Allocated to 
methadone Group 
Received allocated 
intervention (n= 14) 
Analyzed (n= 14) 
Excluded from 
analysis 
(n=0) 
 
Al
loc
ati
on
 
Fo
llo
w 
Up
 
An
aly
sis
 
Lost to follow up 
(n = 0) 
Discontinued 
intervention 
(n= 0) 
 
Allocated to 
bupivacaine Group 
Received allocated 
intervention (n= 17) 
Lost to follow up 
(n = 0) 
Discontinued 
intervention 
(n= 0) 
 
Analyzed (n= 17) 
Excluded from 
analysis  
(n= 0) 
82 
 
 
Appendix H-5 
Perez, J., Jimenez, M.J., Fita, G., Rovira, I., Catalan, M., Gomar, C. (2007). Epidural  
methadone for acute post-thoracotomy pain: An alternative to a ropivacaine plus 
fentanyl-based patient-controlled epidural regimen. Acute Pain 9,193-199.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients enrolled  
(n = 49) 
En
rol
lm
en
t 
Eligible patients  
(n= 49) 
Randomized (n = 49) 
Allocated to ropivacaine 
plus fentanyl  
Received allocated 
intervention (n= 25) 
Lost to follow up 
(n = 0) 
Discontinued 
intervention 
(n= 0) 
 
Analyzed (n= 25) 
Excluded from analysis  
(n= 0) 
Allocated to methadone 
Group 
Received allocated 
intervention (n= 24) 
Analyzed (n= 24) 
Excluded from analysis 
(n=0) 
 
Al
loc
ati
on
 
Fo
llo
w 
Up
 
An
aly
sis
 
Lost to follow up 
(n = 0) 
Discontinued 
intervention 
(n= 0) 
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Appendix I 
Cross Study Analysis  
 Author, 
Year 
Surgery 
Time 
(hours) 
Time to 
Extubation 
(hours) 
Time to 1st 
rescue 
analgesic 
(hours)  
NRS in first 
24 hours   
NRS 
Extended 
period   
Reported 
rescue 
drug use 
Adverse Events  
a Carvalho, 
2011 
methadone: 
2.48-4.23  
 
morphine: 
2.34-3.9 
methadone: 
0.57-7.69 
 
morphine: 
1.23-6.33 
methadone: 
2.43 ± 2.98 
 
morphine: 
4.49 ± 4.22 
methadone: 
1.9 ± 2.2 
 
morphine: 
2.9 ± 2.6 
At 36 
hours: 
 
methadone: 
0.5 ± 1.2 
 
morphine: 
0.5 ± 1.1  
morphine 
use: 
 
methadone
: 29% 
 
morphine: 
43% 
Adverse 
Effects: 
methadone: 16% 
morphine: 19% 
 
Nausea 
methadone: 15% 
morphine: 19% 
 
Vomiting:  
methadone: 5% 
morphine: 3% 
 
Respiratory 
Failure: 
methadone: 2% 
morphine: 1% 
b Udelsmann, 
2011 
 
 
methadone: 
4.75 ± 0.84 
 
morphine: 
4.77 ± 0.96 
methadone: 
7.18 ± 5.07 
 
morphine: 
5.98 ± 2.99 
methadone: 
14.25 ± 
9.89 
 
methadone: 
0.5 ± 0.71 
 
morphine: 
1.84 ± 1.38 
Not 
Applicable  
methadone
: 10/18 
needed 
rescue 
morphine 
PONV* 
methadone: 1/18  
 
morphine: 6/19  
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 Author, 
Year 
Surgery 
Time 
(hours) 
Time to 
Extubation 
(hours) 
Time to 1st 
rescue 
analgesic 
(hours)  
NRS in first 
24 hours   
NRS 
Extended 
period   
Reported 
rescue 
drug use 
Adverse Events  
 
saline: 5.05 
± 1.17  
 
saline: 5.69 ± 
2.41  
 
morphine: 
10.43 ± 
8.75 
 
saline: 8.46 
± 6.88  
 
saline: 2.39 
± 2.18  
 
morphine: 
14/19 
needed 
rescue 
morphine  
 
saline: 
17/18 
needed 
rescue 
morphine   
saline: 9/18   
c Murphy,  
2015 
methadone: 
5.40-7.10  
 
fentanyl: 
5.52-7.12 
methadone:  
5.0-9.5 
 
fentanyl: 
4.75-10.5 
methadone: 
6.5 (3.25-
9.25) 
 
fentanyl: 
3.75 (1.5-
5.75) 
NRS at rest: 
methadone: 
2 (1-4) 
fentanyl: 4 
(2-7) 
 
NRS with 
coughing: 
methadone: 
4 (3-5) 
fentanyl: 7 
(5-9) 
NRS @ 72 
hours at 
rest: 
methadone: 
2 (0-3) 
fentanyl: 3 
(0-5) 
 
NRS @ 72 
hours with 
coughing: 
methadone: 
4 (2-5) 
morphine 
use in first 
24 hours 
(mg): 
 
methadone
:      6 mg 
(4-12)  
 
fentanyl: 
10 mg (6-
22) 
Nausea: 
methadone: 50% 
fentanyl: 56% 
 
Vomiting: 
methadone: 24% 
fentanyl: 19% 
 
Pruritis: 
methadone: 22% 
fentanyl: 12% 
 
Hypoventilatio
n: 
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 Author, 
Year 
Surgery 
Time 
(hours) 
Time to 
Extubation 
(hours) 
Time to 1st 
rescue 
analgesic 
(hours)  
NRS in first 
24 hours   
NRS 
Extended 
period   
Reported 
rescue 
drug use 
Adverse Events  
fentanyl: 5 
(3-7) 
methadone: 4% 
fentanyl: 4% 
 
Hypoxemia: 
methadone: 13% 
fentanyl: 8% 
Sedation: 
methadone: 83% 
fentanyl: 90% 
d Matot, 2004 methadone:  
2.47-4.37 
 
clonidine: 
1.53-4.63 
 
bupivacain
e:  
2.0-4.6 
NR  NR  Per NRS, 
pain score 
was not 
statistically 
significant 
between the 
three 
groups 
throughout 
the study 
period  
 
By POD 3, 
bupivacaine 
group 
required 
more 
NR  diclofenac 
doses 
required 
(mg):  
 
methadone
: 300 ± 120  
 
clonidine: 
325 ± 90 
 
bupivacain
e: 575 ± 
115   
Sedation:  
methadone: 14% 
clonidine: 18% 
bupivacaine: 0% 
 
Hypotension: 
methadone: 0% 
clonidine: 24% 
bupivacaine: 24% 
 
Vomiting:  
methadone: 28% 
clonidine: 6% 
bupivacaine: 12% 
 
Pruritis: 
methadone: 21% 
clonidine: 0% 
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 Author, 
Year 
Surgery 
Time 
(hours) 
Time to 
Extubation 
(hours) 
Time to 1st 
rescue 
analgesic 
(hours)  
NRS in first 
24 hours   
NRS 
Extended 
period   
Reported 
rescue 
drug use 
Adverse Events  
diclofenac 
to achieve 
NRS scores 
<3 at rest 
and <4 
while 
coughing  
bupivacaine: 0% 
 
Bradycardia: 
methadone: 0% 
clonidine: 12% 
bupivacaine: 0%  
 
Urinary 
retention: 
methadone: 28% 
clonidine: 12% 
bupivacaine: 30% 
 
Limb Weakness: 
methadone: 0% 
clonidine: 0% 
bupivacaine: 12% 
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 Author, 
Year 
Surgery 
Time 
(hours) 
Time to 
Extubation 
(hours) 
Time to 1st 
rescue 
analgesic 
(hours)  
NRS in first 
24 hours   
NRS 
Extended 
period   
Reported 
rescue 
drug use 
Adverse Events  
e Perez, 2007 methadone: 
2.3-3.5  
 
ropivacaine 
with 
fentanyl 
(PCEA) : 
2.48-3.32 
Extubated at 
conclusion of 
surgery prior 
to arrival to 
PACU/ICU 
 
NR  
Requested 
rescue 
analgesia: 
 
methadone: 
8.7% 
 
ropivacaine 
with 
fentanyl : 
32% 
At 48 
hours:  
 
Requested 
rescue 
analgesia: 
 
methadone: 
0% 
 
ropivacaine 
with 
fentanyl : 
28% 
 Sedation:  
methadone:  
1 h: 39.1% 
24 h: 13% 
24 h: 13% 
 
PCEA  
1 h: 28%,  
24 h: 0% 
24 h: 4% 
 
Hypotension 
methadone:  
1 h: 0 
24 h: 8.7% 
24 h: 4.3% 
PCEA:  
1 h: 28%,  
24 h: 12% 
24 h: 0 
 
Vomiting 
methadone:  
1 h: 13% 
24 h: 13% 
24 h: 13% 
 
PCEA:  
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 Author, 
Year 
Surgery 
Time 
(hours) 
Time to 
Extubation 
(hours) 
Time to 1st 
rescue 
analgesic 
(hours)  
NRS in first 
24 hours   
NRS 
Extended 
period   
Reported 
rescue 
drug use 
Adverse Events  
1 h: 12% 
24 h: 0% 
24 h: 4% 
 
Pruritis 
methadone: 
1 h 0% 
24 h: 4.3% 
24 h: 0% 
 
PCEA:  
1 h: 0% 
24 h: 4% 
24 h: 4% 
 
PONV= Postoperative Nausea/Vomiting  
NR= Not Reported  
